日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  24(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture An Approach for Development of Immunotherapy Using Cancer-specific Effector Lymphocytes From the Patients with Gynecologic Malignancy--Based on the Characteristics Shared by Malignant and Embryonic Cells Including Tropho-blantic Cells. / S.Takeuchi / p149~149
  • Special Lecture 1. Not Received / /
  • Special Lecture 2. Oncogene Studies and Their Implications on Cancer Treatment / T.Kawakami
  • T.Honjo / p150~150
  • Invitational Lecture 1. Current Management of Ovarian Carcinoma:A Time for Reassessment? / W.T.Creasman / p151~151
  • Invitational Lecture 2. Angiogenesis in Tumor Growth and Metastasis:The Potential Role of Angiogenesis Inhibitors / J.Folkman / p152~153
  • Invitational Lecture 3. Present Status of Adjuvant Therapy in Breast Cancer (Chemotherapy and/or Endocrine Therapy) / R.E.Wilson / p154~154
  • Educational Lecture 1. Not Received / /
  • Educational Lecture 2. Information System to Support Cancer Treatments / S.Kaihara et al. / p155~155
  • Educational Lecture 3. Adult T-cell Leukemia/Lymphoma(ATL) / K.Takatsuki / p156~156
  • Educational Lecture 4. Establishment of Tumor-specific Immunotherapy through the T Cell-T Cell Interaction between Haptenic Determinants and Tumor-resistance Antigens on Tumor Cells / T.Hamaoka / p157~157
  • Educational Lecture 5. Clinical Application of Cytokines to Cancer Treatment / I.Urushizaki / p158~158
  • Educational Lecture 6. Nutritional Management in Cancer Therapy / T.Muto / p159~159
  • Symposium 1 Recent Progress in Cancer Therapy in a Specialized Organ Giving Useful Informations to the Other Specialized Fields -Part 1- / / p160~164
  • 1. Not Received / /
  • 2. On Behalf of Japanese Society of Biological Response Modifiers / K.Ishihara / p160~160
  • 3. On the Activity of the Japanese Research Society for Surgical Cancer Immunology / K.Orita / p161~161
  • 4. Activities of the Japanese Society for Arterial Infusion Chemotherapy Research / T.Taguchi / p162~162
  • 5. Assays for Evaluating the Chemosensitivity of Human Tumors / H.Ichihashi / p163~163
  • 6. Present Situation of Hyperthermia in Cancer Therapy / M.Abe / p164~164
  • Symposium 2 Recent Progress in Cancer Therapy in a Specialized Organ Giving Useful Informations to the Other Specialized Fields -Part 2- / / p165~170
  • 1. Hyperthermia Combined with Chemotherapy and Irradiation for the Treatment of Patients with Esophageal Carcinoma / K.Sugimachi / p165~165
  • 2. The Recent Trend in the Treatment of Stomach Carcinoma and Its Link with the Treatment of Carcinomas in Other Organs / Y.Omori / p166~166
  • 3. Multimodality Treatment for Carcinoma of the Pancreas / R.Tsuchiya et al. / p167~167
  • 4. Prevention and Treatment of the Liver Metastasis from Cancer of the Large Intestine / M.Yasutomi et al. / p168~168
  • 5. Malignant Lymphoma / S.Shirakawa et al. / p169~169
  • 6. Childhood Solid Tumor / T.Fuiimoto / p170~170
  • Symposium 3 Recent Progress in Cancer Therapy in a Specialized Organ Giving useful Informations to the Other Specialized Fields -Part 3- / / p171~175
  • 1. Multidisciplinary Treatment for Malignant Brain Tumors / K.Takakura et al. / p171~171
  • 2. Present Status of Breast Cancer Treatments and Future Prospects / Y.Nomura / p172~172
  • 3. Lung Cancer / K.Suemasu et al. / p173~173
  • 4. Not Received / /
  • 5. Recent Progress in the Treatment of Urogenital Cancer / K.Koiso / p174~174
  • 6. A Recent Trend in the Therapies for Skin Cancers / S.Ikeda / p175~175
  • Symposium 4 Multi-disciplinary Treatment of Cancer--Has It Improved the Results of Treatment? / / p176~180
  • 1. Multidisciplinary Treatment of Leukemia / T.Masaoka / p176~176
  • 2. Multidisciplinary Treatment of Head and Neck Cancer / Y.Inuyama / p177~177
  • 3. Recent Progress in Multidisciplinary Treatment of Hepatic Malignancy / M.Fujita et al. / p178~178
  • 4. An Analysis of Factors Influential to the Improvement of the Survival Rate of Patients with Ovarian Cancer / M.Ohta et al. / p179~179
  • 5. Multidisciplinary Treatment for Advanced Testicular Tumors / T.Kotake et al. / p180~180
  • Symposium 5 Quality of Life in Cancer Therapy / / p181~184
  • 1. Quality of Life in Cancer Treatment:Introduciton / F.Takaku / p181~181
  • 2. Telling the Diagnosis of Cancer / T.Doi / p182~182
  • 3. Cancer Pain Management / F.Takeda / p183~183
  • 4. Quality of Life of the Terminally Ill Cancer Patient--From Experience in Hospice / T.Kashiwagi / p184~184
  • 5. Not Received / /
  • Symposium 6 Significance and Limitations of Extension of Surgery for Cancer / / p185~190
  • 1. Extensive Lymphadenectomy for thoracic Esophageal Carcinoma / S.Mori et al. / p185~185
  • 2. Extended Operations of Cancer--Gastric Cancer / K.Takagi / p186~186
  • 3. The Value and Limit of Extended Operation for Colorectal Cancer / K.Hojo et al. / p187~187
  • 4. Significance of Extended Operation for Pancreas Cancer / I.Miyazaki / p188~188
  • 5. Primary Cytoreductive Surgery for Advanced Ovarian Cancer with Special Reference to the Significance of Bowel Resection / K.Sato et al. / p189~189
  • 6. Extended Surgery for Renal Cell Carcinoma / Y.Aso et al. / p190~190
  • Symposium 7 Adverse Effects and Their Measures in Cancer Therapy / / p191~195
  • 1. Autologous Bone Marrow Transplantation as a Measures against Myelosuppression in Cancer Chemotherapy / T.Tajima et al. / p191~191
  • 2. Not Received / /
  • 3. Not Received / /
  • Additional Utterance Clinical Studies and Pharmacokinetics of Cisplatin With High Dose of Bismuth Subnitrate / T.Morikawa et al. / p192~192
  • 4. Adverse Reactions to Carcinostatics and the Counterplans / I.Nakao / p193~193
  • 5. Infection and Immunosupression in Cancer Patients / T.Kitahara et al. / p194~194
  • 6. The Surgical Stress and Immunosuppression in Cancer Therapy / T.Toge et al. / p195~195
  • 7. Not Received / /
  • Panel Discussion 1 New Developments of Tumor Markers / / p196~197
  • 1. Serum Pepsinogen I Level in Stomach Cancer Patients--Its Values and Limitations in Clinical Use / K.Miki et al. / p196~196
  • 2. Clinical Usefulness of Plasma PIVKA-II Assay and Its Limitations in Patients with Hepatocel-lular Carcinoma / S.Fujiyama et al. / p196~196
  • 3. Diagnostic Usefulness and Limitation of Measurement of Pancreatic Cancer Associate Antigen,Span-1 in Patients with Pancreatic Cancer / K.Satake et al. / p196~196
  • 4. The Usefulness and Limitation of Sugar Antigens in Ovarian Cancers--With Special Reference to a New Tumor Marker CA54/61 / S.Nozawa / p197~197
  • 5. Clinical Application of Immunotoxin for Cancer Therapy
  • Its Possibility and Problem / T.Yamaguchi et al. / p197~197
  • Designated Discussion / N.Sawabu et al. /
  • Panel Discussion 2 New Developments in Imaging Diagnosis for Cancer / / p198~200
  • 1. NMR Spectroscopy of Tumors / M.Itoh et al. / p198~198
  • 2. Computed Tomography(CT)and Magnetic Resonance Imaging(MRI)in the Diagnosis of Gynecologic Cancer / K.Takahashi / p198~198
  • 3. DSA(Digital Subtraction Angiography)--Application of Intraarterial DSA of Bronchial Artery for Lung Cancer / Y.Kuroda / p198~198
  • 4. New Diagnostic Tools Using Proton Beams Obtained from Accelerators in KEK Tsukuba / M.Suzuki et al. / p199~199
  • 5. CCD Endoscope(Stomach) / Y.Okazaki / p199~199
  • 6. Efficacy of Endoscopic Ultrasonography for Malignant Tumor of the Digestive Tract / S.Nakazawa et al. / p199~199
  • 7. Radioimmunoscintigraphy in Malignant Melanoma with In-111 Labeled Monoclonal Anti-body 96.5 and ZME-018 / K.Ishii et al. / p200~200
  • 8. Medical Physics and Cancer Diagnosis by Medical Images / A.Takeshi et al. / p200~200
  • Panel Discussion 3 Mechanisms of Cancer Metastasis--Feedback for Clinical Application / / p201~202
  • 1. Conversion of Tumor Cells from Regressor to Progressor Cells / H.Kobayashi et al. / p201~201
  • 2. Not Received / /
  • 3. Blood Coagulation and Metastasis / Y.Niitsu et al. / p201~201
  • 4. Natural Killer Cells and Metastases / T.Kobayashi / p201~201
  • 5. Metastatic Tumor and Fibrinolytic System / M.Yamamura et al. / p202~202
  • 6. Chemotherapeutic Effect on Metastatic Tumors (`) / H.Takahashi et al. / p202~202
  • 7. Metastatic Tumor and Immunotherapy / S.Fuchimoto et al. / p202~202
  • Panel Discussion 4 Mechanisms of Drug Resistance of Cancer--Feedback for Clinical Application / / p203~204
  • 1. Not Received / /
  • 2. A Molecular Basis for Multidrug Resistance and Reversal of the Resistance / S.Akiyama et al. / p203~203
  • 3. Drug Resistance in Lung Cancer Cells / K.Nakagawa et al. / p203~203
  • 4. Detection of Drug Resistance in Human Hematologic Malignancy by Monoclonal Antibodies / M.Shimoyama et al. / p203~203
  • 5. Effects of Cis-platinum and Adriamycin on Cell Kinetics of Human Ovarian Cancer cells in vitro and Its Characterization of Cisplatinum-resistance / I.Nishiya et al. / p204~204
  • 6. Not Received / /
  • Panel Discussion 5 Clinical Assessment of Second-look Operation in Cancer Therapy / / p205~207
  • 1. Clinical Evaluation of Second Look Operation for Colorectal Cancer / K.Shindo et al. / p205~205
  • 2. Clinical Evaluation of Second Look Operation in Colorectal Cancer / N.Saitoh et al. / p205~205
  • 3. Second Look Operation of Recurrent Gastric Cancer / M.Niimoto et al. / p205~205
  • 4. Gastric Remunant Cancer / K.Ishibiki et al. / p206~206
  • 5. Reevaluation of Second Look Operation(SLO)in the Treatment of Ovarian Cancer Patients / K.Ochiai et al. / p206~206
  • 6. Studies on Second Look Operation(SLO)for Ovarian Cancer / H.Yuzawa / p206~206
  • 7. The Roles of Second Look Surgery in Neuroblastoma / S.Sawaguchi et al. / p207~207
  • 8. Clinical Evaluation of Al Protocol for Advanced Neuroblastoma / M.Iwafuchi et al. / p207~207
  • Panel Discussion 6 Cancer which is Curable by Chemotherapy Alone / / p208~209
  • 1. Curable Cancer by Chemotherapy 1. Acute Myelogenous Leukemia(AML) / R.Ohno / p208~208
  • 2. Malignant Lymphoma / N.Horikoshi / p208~208
  • 3. Combination Chemotherapy with/without Radiation Therapy for Small Cell Lung Cancer:An Experience of Single Institution / T.Ohnoshi / p208~208
  • 4. Gynecologic Malignancies Curable by Anticancer Chemotherapy--Choriocarcinoma and Ovarian Cancer / K.Kanazawa / p209~209
  • 5. Clinical Evaluation of Chemotherapy for urologic Cancer / T.Miki et al. / p209~209
  • Panel Discussion 7 Present Status of Cisplatin Analogue / / p210~211
  • 1. A Prospect for Cisplatin Analogs from the Experimental Standpoint / T.Tashiro / p210~210
  • 2. Pharmacokinetics of New Cisplatin Analogues in Experimental Animals / H.Fujita et al. / p210~210
  • 3. Present Status of Cisplatin(CDDP)Analogues in Japan / H.Majima / p210~210
  • 4. Preclinical and Clinical Evaluation of Toxicities and Antitumor Activities of Cisplatin Analogues / Y.Ariyoshi et al. / p211~211
  • 5. Clinical Evaluation of Cisplatin Analogies in Urogenital Cancer / T.Machida / p211~211
  • 6. Current Status of Cisplatin Analogs in Gynecologic Malignancies / M.Yakushiji et al. / p211~211
  • Panel Discussion 8 Physical and Chemical Therapy Useful in Combined with Irradiation / / p212~214
  • 1. Hypoxic Cell Radiosensitizer / T.Mori / p212~212
  • 2. Experimental Study of Anti-tumor Activity of Direct Current / H.Ito et al. / p212~212
  • 3. The Use of Direct Current for the Local Destruction of Cancer Tissues / M.Yokoyama / p212~212
  • 4. A Study on Application of a Combined Treatment of Endoscopic Laser Irradiation and Radiotherapy on Advanced Lung Cancer / R.One et al. / p213~213
  • 5. The Possibilities of Hyperthermia from Engineering Standpoint / Y.Saitoh et al. / p213~213
  • 6. Biological Basis of Radiotherapy Combined with Physical-chemical treatments / S.Okada / p213~213
  • 7. Clinical Aspects of Adjuvant Physico-chemical Therapy to Radiotherapy / S.Egawa / p214~214
  • Panel Discussion 9 Developments in Adoptive Immunotherapy for Cancer / / p215~216
  • 1. Adoptive Immunotherapy by Intra-arterial Infusion of ATLAK or Allo-TLAK Cells in Patients with Head and Neck Cancer / T.Ikawa et al. / p215~215
  • 2. The Basic and Clinical Studies on Cytotoxic T Lymphocytes(CTl)Therapy against Cancer / K.Kitsukawa et al. / p215~215
  • 3. Clinical and Experimental Studies on OK432-combined Adoptive Immunotherapy Using IL2-cultured Lymphocytes:A New Method to Augment the Therapeutic Effect / N.Kan et al. / p215~215
  • 4. Not Received / /
  • 5. Cultivation of Human Tumor Infiltrating Lymphocytes for Use in Adoptive Immunotherapy / P.Sekine et al. / p216~216
  • 6. Not Received / /
  • Panel Discussion 10 Roles of Therapy by Traditional Chinese Medicine in Cancer Therapy / / p217~220
  • 1. Induction of Phenotypic Reverse Transformation by Plant Glycosides in Cultured Cancer Cells / S.Odashima et al. / p217~217
  • 2. The Production of Antitumor or Immunostimulatory Cytokines by Some Traditional Chinese Medicines / S.Morisawa et al. / p217~217
  • 3. Effects of Hochu-ekkito on Macrophage Activation / T.Tokunaga et al. / p217~217
  • 4. Preventative Effect of TJ-48 on Recovery from Radiation Injury / S.Ikehara / p218~218
  • 5. Not Received / /
  • 6. Immunological Examination of JUZENTAIHO-TO(TJ-48) for Postoperative Gastric Cancer / T.Kurokawa et al. / p218~218
  • 7. Preventing Effect of "Liuwei Dihuang Decoction"on Esophageal Carcinoma / J.Tingliang et al. / p218~218
  • 8. Controlled Prospective Trial to Evaluate Syo-saiko-to for the Prevention of Hepatocellular Carcinoma in Patients with Cirrhosis of the Liver / S.Yamamoto et al. / p219~219
  • 9. Protective Effects of Juzen-taiho-to on the Adverse Effects of Some Anti-tumour Agents / M.Yamashita / p219~219
  • 10. Clinical Effects of Juzen-daiho-to on the Immunological and Fatty Metabolic States in the Postoperatic Patients with Gastro-intestinal Cancer / T.Okamoto et al. / p219~219
  • 11. Role of Supporting Therapy of Juzentaiho-to(JTT)in Advanced Breast Cancer Patient / I.Adachi et al. / p220~220
  • Panel Discussion 11 Present Status in Treatment of Trophoblastic Disease and Its Measures to be Taken in Future in Asia / / p221~221
  • 1. Not Received / /
  • 2. Not Received / /
  • 3. Not Received / /
  • 4. Not Received / /
  • 5. Clinical Experience of Trophoblastic Disease in Nepal / H.Soma et al. / p221~221
  • 6. Trophoblastic Disease in Japan / N.Obata / p221~221
  • Workshop 1 Diagnosis and Treatment of Precancerous Lesions in Various Organs / / p222~226
  • 1. Glandular Dysplasia of the Uterine Cervix--Cytological Diagnosis and a Follow-up Study / H.Higashiiwai et al. / p222~222
  • 2. Diagnosis and Treatement of the Dysplasia of the Uterine Gervix / T.Kaku et al. / p222~222
  • 3. Diagnosis and Treatment of Dysplais of the Uterine Cervix / T.Jobo et al. / p222~222
  • 4. Laser Excisional Conization in the Treatment of Cervical Intraepithelial Neoplasia on an Outpatient Basis / T.Iwasaka et al. / p223~223
  • 5. Diagnosis and Treatment of Endometrial Hyperplasia / K.Tanaka et al. / p223~223
  • 6. Diagnosis of Precancerous Lesions of the Endometrium / H.Iwasaki et al. / p223~223
  • 7. The Effect of Danazol and Tamoxifen on Endometrial Hyperplasia / E.Soh et al. / p224~224
  • 8. Diagnosis and Treatment of Precancerous Lesions of the Bladder by Contact-micro-cystoscopy / M.Nakao et al. / p224~224
  • 9. Follow-up Study of Precancerous Lesion in Breast / K.Enomoto et al. / p224~224
  • 10. Photodynamic Diagnosis and Therapy of Precancerous Lesions of The Bronchus / H.Kato et al. / p225~225
  • 11. Selective Brushings for all Branches of Bronchi:Diagnostic Values Thereof on Patients with Roentogenographically Occult Lung Cancer / M.Sato et al. / p225~225
  • 12. Studies on the Pre-cancerous Lesion of the Colon / T.Igarashi et al. / p225~225
  • 13. The Relationships between Dysplasia and Squamous Cell Carcinoma of the Esophagus / W.Takiyama et al. / p226~226
  • 14. Malignant Progression on Oral Leukoplakia / A.Inoue et al. / p226~226
  • 15. Not Received / /
  • 16. Relation of Karyotypic Findings to Chemotherapy Response in Myelodysplastic Syndrome / S.Horiike et al. / p226~226
  • Workshop 2 Clinical Pathology of Vulvar Tumor / / p227~231
  • 1. A Clinico-pathological Study of Precancerous Lesions of the Vulva / M.Honma / p227~227
  • 2. Clinical Study of 84 Primary Vulvar Carcinomas / T.Yamashiro et al. / p227~227
  • 3. Clinicopathological Study of Early Vulval Cancer / H.Nakajima et al. / p227~227
  • 4. Treatment for the Malignant Vulvar Diseases / T.Saito et al. / p228~228
  • 5. The Comparative Study of Treatments for Vulvar Carcinomas / M.Yamasaki et al. / p228~228
  • 6. Clinical Treatment Study of the Vulvar Cancer / S.Ikeda et al. / p228~228
  • 7. Not Received / /
  • 8. Study of Clinical Background and Therapeutic Method of Vulvar Cancer Patient / N.Umesaki et al. / p229~229
  • 9. Human Papillomavirus DNA in Vulvar Lesions / S.Sato et al. / p229~229
  • 10. Bowenid Papulosis and Bowen's Disease of Genital Region / M.Niimura / p229~229
  • 11. A Case of Verrucous Anogenital Tumor Associated with Human Papillomavirus Infection / T.Nakajima et al. / p230~230
  • 12. A Study on Human Papilloma Virus(HPV)in Penile Tumor / A.Iwasawa et al. / p230~230
  • 13. Genital Paget's Disease / Y.Hayashibara et al. / p230~230
  • 14. Clinical Symptom and Prognosis of Malignant Melanoma in Pubic Region / H.Sasaki et al. / p231~231
  • 15. Surgical Treatment of Malignant Tumors of the External Genital Area / T.Sugihara et al. / p231~231
  • Workshop 3 Improvements in Therapy for Primary Malignant Tumors in Bone and Soft Tissue of Extremities / / p232~236
  • 1. Consideration of Preoperative Systemic Chemotheraphy for Osteosarcoma / H.Chuman et al. / p232~232
  • 2. Limb-salvage Procedures for Malignant Bone Tumors--A Study of 54 Cases / H.Yoshikawa et al. / p232~232
  • 3. Application of Preoperative Chemotherapy to Postoperative Chemotherapy for Malignant Bone and Soft Tissue Tumors / K.Furuse et al. / p232~232
  • 4. Significance of Intra-arterial CDDP as Preoperative Treatment for Osteosarcoma / S.Masuda et al. / p233~233
  • 5. Isolation Perfusion Chemotherapy Using Cisplatin for Malignant Tumor of the Extremity / S.Takeyama et al. / p233~233
  • 6. Historical Improvement in Treatment for Osteosarcoma / H.Kawano et al. / p233~233
  • 7. Angiotensin-induced Hypertension Chemotherapy for Bone and Soft-tissue Sarcomas / H.Tsuchiya et al. / p234~234
  • 8. Preoperative Radiotherapy for Bone and Soft Tissue Sarcomas / S.Matsumoto et al. / p234~234
  • 9. Hyperthermia for Malignant Tumors of the Extremities (3rd report) -Experimental Heating by Radio Waves and Its Clinical Significance- / N.Matsui et al. / p234~234
  • 10. Limb Salvage Procedures for Malignant Bone Tumors of the Extremities / T.Morita et al. / p235~235
  • 11. The Evaluation Method of Surgical Margin for Musculoskeletal Sarcoma / N.Kawaguchi et al. / p235~235
  • 12. Limb-saving Surgery for Malignant Bone Tumor Using Massive Bone Grafts / S.Takeuchi et al. / p235~235
  • 13. Massive Bone Allograft in Bone Tumor Surgery / N.Shinohara et al. / p236~236
  • 14. Clinical Experience of 37 Cases of Soft Tissue Sarcomas in Recent 6 Years / H.Kakizaki et al. / p236~236
  • Workshop 4 Application of the Newly Advanced Culture System to Cancer therapy / / p237~240
  • 1. Not Received / /
  • 2. Changes of DNA Synthetic Cells of Cervical Cancer Cases by Administration of CDDP at the Point of View in Cultured System / T.Izutsu et al. / p237~237
  • 3. The Role of Flow Cytometrical Evaluation of De-differentiation in Human Neuro-blastoma NB6 Cell Line in vitro / H.Yamamoto et al. / p237~237
  • 4. Mechanism of Action of Endocrine Therapy for Endometrial Carcinoma / H.Kuramoto et al. / p237~237
  • 5. Monoclonal Antibodies Raised against Cultured Cells and Their Application to Cancer Diagnosis / S.Nozawa et al. / p238~238
  • 6. Alteration of Phenotype or Drug Sensitivity in Cancer Cell Lines in Different Culture Conditions / J.Sakamoto et al. / p238~238
  • 7. Development of a New Therapeutic Method of Hepatocelluler Carcinoma Using the Culture System--The Intensifying Effect on the Antitumor Action of Antitumor Agents / Y.Hata et al. / p238~238
  • 8. In vitro Chemosensitivity Assay,the Scintillation Assay,and Its Clinical Application / N.Tanigawa et al. / p239~239
  • 9. Culture of LAK Cells by the Use of Hollow-fiber Bioreactor System / U.Tanji et al. / p239~239
  • 10. A New High Yield Continuous Cell Culture System and its Clinical Application for Adoptive Immunotherapy with LAK Cells / T.Noto et al. / p239~239
  • 11. Effects of Thermotherapy on Human Esophageal Carcinoma in Culture and Its Clinical Study / T.Shinbo et al. / p240~240
  • 12. Combination Therapy of Hyperthermia and other Methods for Liver and Bile Tract Cancers--Evaluation of These Methods with Cancer Cell Lines in vitro / S.Hasumura et al. / p240~240
  • 13. The Therapeutic Effects of OK-432 Combined Adoptive Immunotherapy(AIT)against Liver Metastases of Breast Cancer / T.Okino et al. / p240~240
  • Workshop 5 Role of Autopsy for Improvement of Cancer Therapy / / p241~243
  • 1. Significance of Autopsy in the Cases of Gastric Carcinoma / T.Ishiko / p241~241
  • 2. On the Role of Autopsy from The Viewpoint of Pathologists in the School of Medicine / Y.Ohnishi / p241~241
  • 3. An Analysis of Autopsy Cases with Malignant Soft Tissue and Bone Tumors / M.Enjoji et al. / p241~241
  • 4. Evaluation of Cancer Treatment by Autopsy / T.Sugiyama et al. / p242~242
  • 5. The Clinicopathologic Analysis of 46 Autopsied Breast Cancer / S.Takashima et al / p242~242
  • 6. Review of 43 Autopsy Cases with Urogenital Malignant Tumors / M.Yuasa et al. / p242~242
  • 7. Autopsy Findings in 255 Cases of Head and Neck Cancer / S.Matsuura et al. / p243~243
  • 8. Therapentic Analysis with Autopsy Findings Oral Cancer / H.Fukazawa et al. / p243~243
  • General Lecture 1. Augmentation of General Immune Response of Mice with Transplanted Tumor by Oral Administration of OK-432 / Y.Akamatsu et al. / p244~244
  • General Lecture 2. Not Received / /
  • General Lecture 3. Augmentation of Natural Killer Activity of Hepatic Lymphocytes by Portal Administration of BRM / H.Murakami et al. / p244~244
  • General Lecture 4. Chromomycin A₃as an Immunomodulator / M.Kambe et al. / p244~244
  • General Lecture 5. Effects of Recombinant Murine Granulocyte-macrophage Colony-stimulating Factor(rmGM-CSF)on Survial Rate of Mice Infected with Pseudomonas Aeruginosa / T.Tanaka et al. / p245~245
  • General Lecture 6. Anti-tumor Effect of Low Dose X-ray Irradiation in the Tumor-bearing Mice and Spleen Cell Movement / A.Sasaki et al / p245~245
  • General Lecture 7. Effect of BRM on Kupffer Cells-with Special Reference to Superoxide Production and Tumoricidal Activity / T.Sasaoki et al. / p245~245
  • General Lecture 8. Immunotherapy of Murine Renal Cancer(Renca)by OK-432 / S.Tanji et al. / p246~246
  • General Lecture 9. The Effectiveness on Intratumoral Injection of Biological Response Modifiers as Adoptive Immunotherapy / M.Takahashi et al. / p246~246
  • General Lecture 10. Experimental Study of Oral Administration of SSM (an Extract from Human Tubercle Bacilli) / K.Iida et al. / p246~246
  • General Lecture 11. Prophylactic Effects of OK-432 and Anticancer Drugs on Hepatic Metastases of Mouse Colorectal Tumors / Y.Nishiyama et al. / p247~247
  • General Lecture 12. Establishment of Anti-tumor Immunotherapy Utilizing Lactobacillus Casei(LC 9018) / Y.Shimizu et al. / p247~247
  • General Lecture 13. The Suppression Effect of Repetitive Intraportal Administration of Recombinant Interleukin 2(rIL2)and Anticancer Drug for Liver Metastasis in Rabbit VX2 Model / M.Iwasaki et al. / p247~247
  • General Lecture 14. Effect of Crude IL-2 on Cytotoxic Activity on Cultured Metastatic Lymphonode Lymphocyte in Murine Model / M.Nakanishi et al. / p248~248
  • General Lecture 15. Anti-tumor Effect of Liposome-entrapped Tumor Necrosis Factor against Brain Tumor / J.Ishiyama et al. / p248~248
  • General Lecture 16. Antitumor Effect of Recombinant Human Interleukin-1β in Combination with Natural Human Tumor Necrosis Factor-α and-β on BDF-1 Mice Bearing Lewis Lung Carcinoma / M.Ohkura et al. / p248~248
  • General Lecture 17. Antiproliferative Effect of TNFs and IFNs on Experimental Hepatic Metastasis / E.Sanada et al. / p249~249
  • General Lecture 18. Not Received / /
  • General Lecture 19. Immunochemotherapy for Murine Bladder Tumor(MBT-2)with a New Recombinant Tumor Necrosis Factor(rTNF-S AM2) / T.Iizumi et al. / p249~249
  • General Lecture 20. Enhancement of Walker-256 Antitumor Effect by Intraarterial Administration of TNF before Using Mitomycin C / T.Sato et al. / p249~249
  • General Lecture 21. The Role of Intracellular Ca²⁺in the Mechanism of TNF-cytotoxicity / M.Maeda et al. / p250~250
  • General Lecture 22. Enhanced Antitumor Effect against a Nonimmunogenic Tumor by Highly Immunogenic Variant Obtained by Mutagen Treatment / R.Sainouchi et al. / p250~250
  • General Lecture 23. Augmentation of LAK Cell-Accumulation in the Region of Tumors by Cancer Chemotherapy / M.Hosokawa et al. / p250~250
  • General Lecture 24. Life-prolonging Effect of Low-dose IL2 / N.Kan et al. / p251~251
  • General Lecture 25. Studies on Administration and Efficacy of Autologous Lymphocytes Sensi-tized with Solid Tumor in Animal Model / M.Hirokawa et al. / p251~251
  • General Lecture 26. Adoptive Immunotherapy of Advanced Visceral Metastases with in vitro Sensitized(IVS)Tlymphocytes from Tumor-bearing(TB)Mice / T.Chou et al. / p251~251
  • General Lecture 27. The Antitumor Effective Research of Combinant Therapy of Mouse IFN-γ and Antitumor Medicine(CDDP) / M.Sugiyama et al. / p252~252
  • General Lecture 28. Therapeutic Effect of Xenogenized Tumor Cell Vaccine Combined with Bleomycin(BLM)or Cyclophosphamide(CY)against Rat Fibrosarcoma / M.Komatsumoto et al. / p252~252
  • General Lecture 29. Clinical Examination of Renal Pelvic and Ureteral Tumors / S.Uejima et al. / p252~252
  • General Lecture 30. Statistical Analyses on Tumors of Renal Pelvis and Ureter / T.Nagai et al. / p253~253
  • General Lecture 31. Statistical Studies of Superficial Bladder Tumor / K.Toyoda et al. / p253~253
  • General Lecture 32. Statistical Study on Bladder Tumor / Y.Thachibana et al. / p253~253
  • General Lecture 33. G3Tl Tumors in the Development of Transitional Cell Carcinoma of the Urinary Bladder / Y.Tanaka et al. / p254~254
  • General Lecture 34. Uroepithelial Tumors of Upper Urinary Tract following the Therapy of Bladder Cancers / H.Ohashi et al. / p254~254
  • General Lecture 35. Significance of Diagnosis and Treatment on Prostate Cancer Stage A / T.Hachiya et al. / p254~254
  • General Lecture 36. Clinical Evaluation of Patients with Relapsed Prostatic Carcinoma / Y.Uekado et al. / p255~255
  • General Lecture 37. Clinical Observations on Squamous Cell Carcinoma of the Penis / K.Fukuda et al. / p255~255
  • General Lecture 38. Treatment for Penile Carcinoma-analysis on 14 Cases / T.Tsukamoto et al. / p255~255
  • General Lecture 39. Clinical Studies on 29 Cases of Testicular Tumors / S.Kawamura et al. / p256~256
  • General Lecture 40. A Clinicostatistical Analysis of Testicular Tumor / M.Saegusa et al. / p256~256
  • General Lecture 41. Pathohistologicai and Immunological Resarch of Spontaneous Regression or Long Survival Cancer Cases (XIV) -The Analytical Study of the Gastric Cancer Patients- / S.Nakagawa et al / p256~256
  • General Lecture 42. Autopsy Findings in 49 Cases of Esophageal Cancer / K.Sakaino et al. / p257~257
  • General Lecture 43. Not Received / /
  • General Lecture 44. A Study of the Recurrence in the Remnant Liver of Hepatocellular Carcinoma in Relation to the Mode of It's Growth / M.Yamamoto et al. / p257~257
  • General Lecture 45. Clinico-pathological Investigation of 25 Leiomyosarcomas of Alimentary Tract / N.Kadoya et al. / p257~257
  • General Lecture 46. Head and Neck Cancer in Aged Popuration / K.Hayasaki et al. / p258~258
  • General Lecture 47. Neck Dissection Combined with Radiotherapy for the Metastatic Node,6cm in Diameter / H.Matsuura et al. / p258~258
  • General Lecture 48. An Evaluation of the Treatment of Nonsquamous Cell Malignancies of the Nose and Paranasal Sinuses / M.Igarashi et al. / p258~258
  • General Lecture 49. Clinical Study for the Promoting Factor of the Tongue Cancer in Younger Adults / Y.Kimura et al. / p259~259
  • General Lecture 50. The Clinical and Pathological Study of Recurrent Thyroid Cancer / M.Sasaki et al. / p259~259
  • General Lecture 51. Long Term Survivors in Small Cell Lung Cancer Patients / M.Yamamoto et al. / p259~259
  • General Lecture 52. Clinical Study of the Treatment and Prognosis of Small Cell Lung Cancer(SCLC) / T.Tsuburaya et al. / p260~260
  • General Lecture 53. Prognostic Factor in Patients with Primary Ovarian Cancer / T.Nakano et al / p260~260
  • General Lecture 54. An Analysis of Prognostic Factors in Ovarian Cancer Patients with Poor Prognosis / T.Kita et al. / p260~260
  • General Lecture 55. Clincal Evaluation of Chemotherapy for Ovarian Embfyonal Carcinoma / T.Chiba et al / p261~261
  • General Lecture 56. Mass Screening for Uterine Cancer in Oita Prefecture after Enforcement of Rhozin Hokenlow / I.Taniguchi et al. / p261~261
  • General Lecture 57. Not Received / /
  • General Lecture 58. Occurrence of Choriocarcinoma after Chemotherapy for Invasive Mole / S.Hirose et al. / p261~261
  • General Lecture 59. Choriocarcinoma Following Normal Labor-the Result of Registry in Shizuoka Prefecture and Three Cases Recently Seen in Our Hospital / M.Maeda et al. / p262~262
  • General Lecture 60. Tumor Volume and Histologic Type in the Evaluation of Cervical Cancer Prognosis / Y.Nakai et al. / p262~262
  • General Lecture 61. Adenocarcinomas and Mixed Carcinomas of the Uterine Cervix: Clinicopathological Study for the Prognostic Factors / I.Konishi et al. / p262~262
  • General Lecture 62. Prognostic Significance of Langerhans Cell Infiltration in Adenocarcinoma of the Uterine Cervix / T.Nakano et al. / p263~263
  • General Lecture 63. Study on Squamous Cell Carcinoma of the Uterine Cervix According to New FIGO Staging / Y.Gyotoku et al. / p263~263
  • General Lecture 64. Study of Risk Factors in Postoperative Cases of the Endometrial Cancer / Y.Hashimoto et al. / p263~263
  • General Lecture 65. Analysis of Prognostic Factors in Endometrial Carcinoma / S.Ohkawara et al. / p264~264
  • General Lecture 66. Investigation on the Cases with Recurred Uterine Endometrial Cancer in Our Clinic / Y.Kondo et al. / p264~264
  • General Lecture 67. Multivariate Analysis of Prognostic Factors for Renal Cell Carcinoma / K.Ohmura e tal. / p264~264
  • General Lecture 68. Computerized Follow-up System of the Cancer Patients / K.Kaliwara et al. / p265~265
  • General Lecture 69. Hazard Ratio Estimated from a Proportional Hazard Model Including Two Strongly Correlated Prognostic Factors / N.Hamajima et al. / p265~265
  • General Lecture 70. Hypothesis of Combined Immune and Respiratory Disorders in Relation to the Nature of Cancer, and a Flow Chart of the Therapy / M.Mori / p265~265
  • General Lecture 71. From Six Cases of Multiple Primary Malignant Neoplasm / K.Tsuchikawa et al. / p266~266
  • General Lecture 72. Second Primary Malignancies in 373 Patients with Laryngeal Cancer / T.Fujii et al. / p266~266
  • General Lecture 73. Early Gastric Carcinoma--With Special Reference to Postoperative Recurrence and Primary Carcinoma of Other Organs Following Gastrectomy / H.Maekawa et al. / p266~266
  • General Lecture 74. A Cohort Study of Multiple Primary Cancer on 870 Gastrectomy Cases / M.Kamakura et al. / p267~267
  • General Lecture 75. A Case Study of Double Malignancies, Chorangiocarcinoma and Adrenal Neuroblastoma Treated with Combined Chemotherapy Regimen of Cyclo-phosphamide,Vincristine,Adriamycin,and Dimethyl Triazeno Imidazole Cafrboxamide(CYVADIC) / T.Watanabe et al. / p267~267
  • General Lecture 76. Multiple Primary Cancers Associated with Gynecologic Malignancies / M.Shinohara et al. / p267~267
  • General Lecture 77. Phase II Clinical Study of 254-S[(Glycolato-O,O')Diammine Pt(II)],a New Platinum Complex,for Primary Lung Cancer (Prelimiary Report) / K.Kubota et al. / p268~268
  • General Lecture 78. Phase II Study of 254-S for Non-small Cell Lung Cancer / M.Fukuda et al. / p268~268
  • General Lecture 79. Phase II Study of 254-S for Gynecologic Malignancy / H.Nishimura et al. / p268~268
  • General Lecture 80. Studies on Absorbing Pathways and Effect of KM2210(Bursamustin)on Recurrent and Advanced Breast Cancers / Z.Yamazaki et al. / p269~269
  • General Lecture 81. Phase I Clinical Study of KRN 8602 / H.Majima / p269~269
  • General Lecture 82. Phase I Study of CPT-11,a Derivative of Camptothecin / H.Furue et al. / p269~269
  • General Lecture 83. Pharmacokinetics of CPT-11,a Newly Semisynthesized Anticancer Agent Camptotecin(CPT) / K.Morimoto et al. / p270~270
  • General Lecture 84. Not Received / /
  • General Lecture 85. Not Received / /
  • General Lecture 86. Chemopreventive Effect of Antineoplaston A-10 on Urethane Induced Pulmonary Neoplasm in Mice / H.Yoshida et al. / p270~270
  • General Lecture 87. Lysis of Leukemic Cells by Human Macrophages / M.Sasada et al. / p270~270
  • General Lecture 88. Generation of Lymphokine-activated Killer Cells with Different Surface Phenotype by Cultivation with Recombinant Interleukin 2 and/or Recombinant Interferone γ or T-cell Growth Factor in Gastric Cancer Patients / S.Koyama et al. / p271~271
  • General Lecture 89. The Function of Non-parenchymal Liver Cells(2nd Report)Enhancement of Cytotoxity of Pit Cells in Rat Liver by Interleukin 2 / A.Yamauchi et al. / p271~271
  • General Lecture 90. Rapid Induction of Activated Killer Cells by PWM Conjugated Acrylate Beads(CMC-1) / S.Ohno et al. / p271~271
  • General Lecture 92. Induction of Cytokines in Ascites of Patients with Ovarian Cancer by OK-432 and Ascitic Supernatant's Inhibition Effect on Colony Formation of Autologous Carcinoma Cells / N.Ito et al. / p272~272
  • General Lecture 93. Induction of Cytokines in Ascites of Patients with Ovarian Cancer by OK-432 / H.Mori et al. / p272~272
  • General Lecture 94. Augmentation of Interleukin-2 Receptor Expression of Peripheral Blood Lymphocytes Stimulated in vitro OK-432 / K.Hamagashira et al. / p272~272
  • General Lecture 95. Effects of OK 432 On Interaction of Lymphocytes with Autologous Tumor Cells / A.Uchida et al. / p273~273
  • General Lecture 96. Induction of Activated Killer Cells Challenged in vitro with Lentinan as Polysaccharides / M.Tani et al. / p273~273
  • General Lecture 97. B.R.M-like Activities of Analogues to Eisenine,a Tripeptide Extracted from a Maline Alga,the So-called "Arame" / T.Kojima et al. / p273~273
  • General Lecture 98. Anti-tumor Effect of Recombinant Human Lymphotoxin Derived from CHO Cells on a Tumor Line of Human Glioma / T.Mikami et al. / p274~274
  • General Lecture 99. Anti-tumor Effect of Human Recombinant Tumor Necrosis Factor(Hu-rTNF)on Brain Tumor Cells / K.Sakamoto et al. / p274~274
  • General Lecture 100. Antiproliferative Effect of rIFN-β,-γ and Medroxyprogesterone Acetate(MPA)on the Human Breast Cancer Cell Line ZR-75-1 / S.Shiiki et al. / p274~274
  • General Lecture 101. Mechanism of the Synergism between nHuIFN-α,γ and nHuTNF-α,β in Cell Cycle Progression / M.Muro et al. / p275~275
  • General Lecture 102. Not Received / /
  • General Lecture 103. Protective Effect of Intracellular Glutathione against TNF Cytotoxicity / N.Yamauchi et al. / p275~275
  • General Lecture 104. Study of Direct Anti-tumor Effect of r-Hu-TNF-α on Human Renal Cell Carcinomas Heterotransplanted in Nude Mice / K.Nakauchi et al. / p275~275
  • General Lecture 105. Direct Anti-cancer Effect of OK-432,IFN-gamma and IFN-alpha aganist Human Urogenital Cancers Xenografted into Nude Mice / Y.Hosoya et al. / p276~276
  • General Lecture 106. Antiproliferative Effects of Human Recombinant Tumor Necrosis Factor on Gynecologic Tumor Cells in vitro (Combined Effect with Interferons or Anticancer Drugs) / H.Kondo et al. / p276~276
  • General Lecture 107. Study of UFT with Simultaneous Administration of Interferon Using Established Human Renal Cell Carcinoma Heterotransplanted into Nude Mice / H.Shirakawaet al. / p276~276
  • General Lecture 108. Study of Radiotherapy with Smimultaneous Administration of Interferon Using Established Human Renal Cell Carcinoma Heterotransplanted into Nude Mice / H.Kurauchi et al. / p277~277
  • General Lecture 109. Immunohistochemical Approach to Reveal the Cell Cycle of Uterine Cancer / M.Yoshinouchi et al. / p277~277
  • General Lecture 110. Quantitative Nuclear DNA Analysis of Epitherial Ovarian Tumors / S.Hirata et al. / p277~277
  • General Lecture 111. Morphological in Vestigations of TTK-2 Cell Line Derived from Normal Busal Decidual Tissue / K.Hashii et al. / p278~278
  • General Lecture 112. Studies on the Neoplastic Transformation of the TTK-2 Cell Line Derived from Normal Human Decidua / I.Tateyama et al. / p278~278
  • General Lecture 113. Immunohistological Study of Enhancement of MHC Antigen Expression by Interferon-gamma / T.Tanaka et al. / p278~278
  • General Lecture 114. The Application of Laser Scanning Microscopy to Cell Biology (The Structure,Characteristics, and Basic Experiment) / M.Sugita et al. / p279~279
  • General Lecture 115. DNA Ploidy Using Paraffin-embedded Materials in Urological Cancer / M.Yamamoto et al. / p279~279
  • General Lecture 116. Study of Simultaneous Flow Cytometric BrdU/DNA Analysis with Urological Tumors / T.Shimabukuro et al. / p279~279
  • General Lecture 117. Cell Cycle Kinetics of Human Prostate Cancer / K.Hattori et al. / p280~280
  • General Lecture 118. Studies of Bladder Cancer by a Two-parameter DNA-RNA Microspectrophotometric Analysis / H.Yamamoto et al. / p280~280
  • General Lecture 120. Analysis of Cell Cycle by BrdU Labeling Method Using Flow Cytometry / Y.Tsuji et al. / p280~280
  • General Lecture 121. The Correlation of Expressing a Nuclear Antigen Reactive with Monoclonal Antibody Ki-67 with Degree of Malignancy in Gastric Cancer / T.Kamata et al. / p281~281
  • General Lecture 122. Thymidine Kinase and Thynidylate Synthetase Activities in Human Gastric Cancer / Y.Kawachi et al. / p281~281
  • General Lecture 123. Detection of the Growth Fractions in Colorectal Cancer by Monoclonal Antibody against DNA Polymerase α / A.Yamaguchi et al. / p281~281
  • General Lecture 124. Flow Cytometric Analysis of DNA Histogram in Rectal Carcinoma / Y.Araki et al. / p282~282
  • General Lecture 125. Expression of Carbohydrate Antigens on Leucocyte Surface Membranes / K.Orimo et al. / p282~282
  • General Lecture 126. The Mode of Liver Metastasis and Survival Rate of the Patients with Liver Metastasis of Digestive Organ Cancer / S.Imaoka et al. / p282~282
  • General Lecture 127. Treatment of Simultaneous Liver Metastasis from Colorectal Carcinoma / T.Utsunomiya et al. / p283~283
  • General Lecture 128. Hepatic and Pulmonary Metastasis in Patients with Rectal Cancer Following the Curative Surgery / T.Sawada et al. / p283~283
  • General Lecture 129. Clinicopathological Study of DNA Histogram Pattern and Liver Metastasis in Colorectal Carcinoma / K.Kurooka et al. / p283~283
  • General Lecture 130. Expression of Cancer-associated Carbohydrate Antigens in Primarry Lesion and Liver Metastatic Lesion of Colorectal Cancer / Y.Arisawa et al. / p284~284
  • General Lecture 131. Venous Invasion and Liver Metastasis of Colorectal Cancer in Immunohistochemistry of Laminin / R.Kubo et al. / p284~284
  • General Lecture 132. Prevention of Liver Metastasis of Colonic Cancer by Portal Administration of ACNU-Lipiodol in Mice / J.Wakasugi et al. / p284~284
  • General Lecture 133. Clinicopathological Study of Malignant Lesion in the Gastric Remnant / S.Ishii et al. / p285~285
  • General Lecture 134. Clinicopathological Investigation of Early Gastric Cancer with Emphasis on the Fatal Factors / S.Tanaka et al. / p285~285
  • General Lecture 135. Clinical Evaluation of the Area of Serosal Invasion in Gastric Cancer / H.Nishidoi et al. / p285~285
  • General Lecture 136. Immunohistochemical Localization of Carbohydrate Antigen 19-9 in Gastric Cancer / N.Tanimoto et al. / p286~286
  • General Lecture 137. Localization of CEA and CA19-9 in Well-differentiated Early Cancer,Atypical Epithleium and Ulcer of the Stomach / K.Kohfuji et al. / p286~286
  • General Lecture 138. A Study of Localization of Fibronectin and Laminin in Human Gastric Cancer / T.Mukai et al. / p286~286
  • General Lecture 139. Immunohistological Study of Laminin(LN)and Type IV Collagen(CIV)in Colorectal Cancer / J.Hida et al. / p287~287
  • General Lecture 140. Not Received / /
  • General Lecture 141. Cytokeratin Pattern in Bladder Cancer Immunohistochemical Investigation / M.Ueno et al. / p287~287
  • General Lecture 142. Usefulness of the Presence of β-human Chorionic Gonadotfopin(β-HCG)in Bladder Tissue for Evaluation of Bladder Cancer / K.Fukunaga et al. / p287~287
  • General Lecture 143. A Clinical Value of Urinary Cytology in Followup Cases of Bladder Tumor / K.Ebisui et al. / p288~288
  • General Lecture 144. Clinical and Pathological Study of Prostatic Carcinoma / H.Koike et al. / p288~288
  • General Lecture 145. Histological and Histochemical Analysis of Responsiveness of Prostatic Cancer to Various Therapies / N.Moriyama et al. / p288~288
  • General Lecture 146. Results of Segmental and en bloc Resection for Urachal Carcinomas / T.Yamada et al. / p289~289
  • General Lecture 147. Superficial Cancer Spread and its Regional Nodal Metastasis in Early Gastric Cancer / K.Uchida et al. / p289~289
  • General Lecture 148. Evaluation of Gastric Cancer Resected Palliatively Because of Unresectable Lymph Node Metastasis / T.Nakadate / p289~289
  • General Lecture 149. Retroperitoneal Lymph Node Metastasis and Intraperitoneal Spreading in Ovarian Cancer / T.Kasamatsu et al. / p290~290
  • General Lecture 150. Investigation of Para-aortic Lymphnode Metastases in Gynecologic Cancers / M.Higashi et al. / p290~290
  • General Lecture 151. Not Received / /
  • General Lecture 152. Perivesical Micrometastasis of Bladder Carcinoma / Y.Hiraoka et al. / p290~290
  • General Lecture 153. Clinicopathological Study of Distant Metastasis from the Carcinoma of the Head and Neck Origin / W.Nishijima et al. / p291~291
  • General Lecture 154. The Incidence of Remote Metastasis Recurrence after Curative Operation of Differentiated Thyroid Cancer / S.Noguchi et al. / p291~291
  • General Lecture 155. Mechanism of lung Metastasis from Colo-rectal Cancer / M.Kameyama et al. / p291~291
  • General Lecture 156. A Retrospective Survey about Pulmonary Metastasis of Cervical Carcinoma / M.Takemura et al. / p292~292
  • General Lecture 157. Neo-adjuvant Chemotherapy for Osteosarcoma-prognosis of the Cases with Pulmonary Metastasis / H.Shimizu et al. / p292~292
  • General Lecture 158. Surgical Manipulation of VX2 Carcinoma in the Liver Evokes Enhancement of Metastasis in Rabbits / T.Nishizaki et al. / p292~292
  • General Lecture 159. Histopathological Findings of the Endometrium on Peri-and/or Post-menopausal Uterine Bleedings / T.Kagabu et al. / p293~293
  • General Lecture 160. Cytomofphological Features of Endometrial Hyperplasia / K.Yamauchi et al. / p293~293
  • General Lecture 161. Endometrial Cancer in Young Women / H.Sawai et al. / p293~293
  • General Lecture 162. Clinico-pathologic Study of Serous(Papillary)Adenocarcinoma of the Endometrium / Y.Hirai et al. / p294~294
  • General Lecture 163. Study on Patho-histologic Findings and Clinical Course of Uterine Sarcoma / Y.Iizuka et al. / p294~294
  • General Lecture 164. The Importance of Cytology Screening in Pregnant Women / M.Kamiwatari et al. / p294~294
  • General Lecture 165. Cervical Conizationand Stage Ib Occult Carcinoma of the Uterine Cervix / M.Ikeuchi et al. / p295~295
  • General Lecture 166. Clinicopathological Study on the Histological Types of Cervical Cancer / N.Yukimuraet al. / p295~295
  • General Lecture 167. A Clinicopathological Study on Adno and Adenosquamous(mixed)Carcinoma of the Uterine Cervix / K.Ohmi et al. / p295~295
  • General Lecture 168. A Case of Pregnancy Complicated with a Malignant Tumor of the Ovary / M.Okamoto et al. / p296~296
  • General Lecture 169. A Clinicopathdogic Study for 19 Patients with Paget's Disease of the Vulva / S.Kodama et al. / p296~296
  • General Lecture 170. Analysis on Metastatic Bone Tumors / Y.Kagami et al. / p296~296
  • General Lecture 171. Not Received / /
  • General Lecture 172. Clinical Study of Renal Cell Carcinoma with Bony Metastasis (Comparative Study with Lung Metastasis) / T.Onishi et al. / p297~297
  • General Lecture 173. Combination Chemotherapy Combined with Surgical Resection for the Bladder Cancer Patients Presented with Bone Metastasis / S.Nomura et al. / p297~297
  • General Lecture 174. Not Received / /
  • General Lecture 175. Diagnosis and Treatment for the Skeletal Metastases of Cancer / K.Saotome et al. / p297~297
  • General Lecture 176. A Clinical Study of Skull Metastases of Malignant Neoplasms / J.Onda et al. / p298~298
  • General Lecture 177. Metastatic Melanoma in Brain-A Successful Case Treated DTIC / M.Kobayashi et al. / p298~298
  • General Lecture 178. Brain Metastases in Patients with Breast Cancer / T.Tabei et al. / p298~298
  • General Lecture 179. Clinical Study of Delayed Brain Metastasis from Small Cell Lung Cancer(SCLC) / N.Takifuji et al. / p299~299
  • General Lecture 180. Treatment of Brain Metastases from Lung Cancer in the Aged Patients / R.Nishikawa et al. / p299~299
  • General Lecture 181. Prostatic Carcinoma Metastatic to Choroid / D.Horiuchi et al. / p299~299
  • General Lecture 182. Prognosis of Choriocarclnoma with Brain Metastasis / T.Imamura et al. / p300~300
  • General Lecture 183. A Clinicopathological Study of Precancerous Condition of Oral Mucosa / T.Fukuda et al. / p300~300
  • General Lecture 184. Pathological Examination of Biopsies in Mesopharyngeal Lesions in 271 Specimens / R.Shimizu et al. / p300~300
  • General Lecture 185. Immunohistochemical Study of Head and Neck Cancers / J.Hirota et al. / p301~301
  • General Lecture 186. Immunohistochemical Study of the Head and Neck Cancer / N.Hyo et al. / p301~301
  • General Lecture 187. Histologic Evaluation of Seventy Cases of Gingival Carcinoma / M.Takita et al. / p301~301
  • General Lecture 188. Clinicopathological Analysis of Transglottic Cancer / K.Umatani et al. / p302~302
  • General Lecture 189. Immunohistochemical Localization of Intermediate-sized Filaments in Salivary Gland Tumors / R.Matsushima et al. / p302~302
  • General Lecture 190. Positron Emission Tomography(PET)Imaging Using Labelled Amino Acids in Patients with Gliomas / K.Mineura et al. / p302~302
  • General Lecture 191. Value of Gd-DTPA in MRI of Spinal Cord Tumors / K.Yoshida et al. / p303~303
  • General Lecture 192. The Utility of Ultrasound in Metastatic Lymphnodes of Head and Neck Tumor / R.Nishimura et al. / p303~303
  • General Lecture 193. CT Evaluation of Malignant Lymphoma of the Head and Neck / I.Yamada et al. / p303~303
  • General Lecture 194. The Relationship between the Mitosis of Thyroid Cancer and the Thermographic Findings / H.Usuki et al. / p304~304
  • General Lecture 195. Evaluation of Clinical Application of 31P-MRS to Presurgical Chemotherapy for Malignant Bone and Soft Tissue Tumors / T.Kojima et al. / p304~304
  • General Lecture 196. Clinical Trend of Chemotherapy for Osteosarcoma / S.Yamawaki et al. / p304~304
  • General Lecture 197. Studies on the Anticancer Drug Sensitivity Test against Human Ovarian Tumor--The Effect of Danazol / H.Chiba et al. / p305~305
  • General Lecture 198. Fundamental Studies of Subrenal Capsule Assay--Drug Administration under Immunosuppfessed Condition / K.Ushijima et al. / p305~305
  • General Lecture 199. Subrenal Capsule Assay in Gynecological Malignancies for Oral Adjuvant Chemotherapy / I.Sekiguchi et al. / p305~305
  • General Lecture 200. Correlation between the Results from Snbrenal Capsule Assay and the Clinical Responses in the Gynecological Malignancies / N.Kamiya et al. / p306~306
  • General Lecture 201. Investigation of Relationships between Predictive Testing of Uterine Cancer to UFT by Subrenal Capsule Assay and by Inhibition of Thymidylate Synthase and Levels of 5-Fu in Tumor Tissues / M.Suzuki et al. / p306~306
  • General Lecture 202. Predictive Tesring of Choriocarcinoma to Chemotherapy by the Subrenal Capsule Assay / M.Ogiao et al. / p306~306
  • General Lecture 203. Human Tumor Clonogenic Assay for Gynecologic Cancers / H.Fujita et al. / p307~307
  • General Lecture 204. Not Received / /
  • General Lecture 205. Drug Sensitivity of Four Established Choriocarcinoma Cell Lines and the Clinical Courses of Their Original Patients / S.Goto et al. / p307~307
  • General Lecture 206. Not Received / /
  • General Lecture 207. Clinical Application of in vitro Drug Sensitivity Test for Osteosarcoma / J.Kakizaki et al. / p307~307
  • General Lecture 208. Evaluation of Additive Effect on Anti-cancer Agents by Mouse Sarcomas--By"Intra Test-tube Contact to Drugs and Subcutaneous Inoculation Method" / O.Inoue et al. / p308~308
  • General Lecture 209. Transrectal Ultrasonography for Cervical Cancer / T.Nagano et al. / p308~308
  • General Lecture 210. CT Findings and Prognosis of Cervix Carcinoma / N.Narimatsu et al. / p308~308
  • General Lecture 211. Evaluation of Myometrial Invasion by Endometrial Carcinoma Using Transvaginal Sonography / I.Honda et al. / p309~309
  • General Lecture 212. Not Received / /
  • General Lecture 213. The Application of Magnetic Resonance Imaging(MRI)to Endometrial Carcinoma / M.Yamasaki et al. / p309~309
  • General Lecture 214. MRI of Uterine Malignancies / H.Kaneko et al. / p309~309
  • General Lecture 215. Correlation of Computed Tomography and Serum Tumor Markers in Follow-up and Evalua-tion of Patients with Recurrent Ovarian Cancer / Y. Wakabayashi et al. / p310~310
  • General Lecture 216. Assessment of Magnetic Resonance Imaging in Diagnosis and Treatment of Ovarian Tumor / M. Kawamura et al. / p310~310
  • General Lecture 217. ¹³¹I-monoclonal Antibody OC-125 F (ab') for Diagnostic Injection / M. Nagashima et al. / p310~310
  • General Lecture 218. Quantitative Analysis of Digital Substraction Angiography in Invasive Mole / M. Ohashi et al. / p311~311
  • General Lecture 219. Clinical Evaluation of Lung Perfusion Scintigraphy for Renal Cell Carcinoma with Venous Thrombosis / H. Shiraiwa et al. / p311~311
  • General Lecture 220. Not Received / /
  • General Lecture 221. A Study of Photon Counting Imaging of Hematoporphyrin Derivative (HpD) Fluorescence for Bladder Cancer Detection / T. Misaki et al. / p311~311
  • General Lecture 222. A Study of Surbrenal Capsule Assay with Immuno Suppressive Agents against Esophageal Cancer / M. Terashima et al. / p312~312
  • General Lecture 223. Evaluation of Subrenal Capsule Assay Using BDF1 Mice with Cyclosporin A to Gastrointesti-nal Cancer / T.Satta et al. / p312~312
  • General Lecture 224. Study of the Effect of Anticancer Drugs on the DNA Histogram of Tumor Cell in vivo / T. Kosaka et al. / p312~312
  • General Lecture 225. Experimental and Clinical Study on Tumor Heterogeneity of DNA Contents and Chemosen-sitivities / T.Shimomatsuya et al. / p313~313
  • General Lecture 226. The Importance of Histological Study in Subrenal Capsule Assay / H.Anzai et al. / p313~313
  • General Lecture 227. Chemosensitivity Test by SRCA for Liver Cancer Specimens Obtained by Fine Needle / H.Fukushima et al. / p313~313
  • General Lecture 228. Not Received / /
  • General Lecture 229. The Evaluation of Chemosensitivity Test for Esophageal Cancer by ATP Assay Using Endoscopic Biopsy / K.Kawano et al. / p314~314
  • General Lecture 230. In vitro Human Tumor Chemosensitivity Testing Based on Intracellular ATP Levels(Human Tumor ATP Assay) / M.Miura et al. / p314~314
  • General Lecture 231. An Experimental Study for Anticancer Agent Sensitivity Test in Human Gastric Cancer Cell Lines by Flow Cytometry / N.Katayanagi et al. / p314~314
  • General Lecture 232. Simplified Scintillation Assay for Chemosensitivity Testing of Malignant Effusion / T.Wada et al. / p315~315
  • General Lecture 233. Chemosensitivity of Human Anaplastic Thyroid Carcinoma Serially Transplanted into Unde Mice / A.Yoshida et al. / p315~315
  • General Lecture 234. Study of Ultrasonic Examination in the Diagnosis of Breast Cancer / T.Koida et al. / p315~315
  • General Lecture 235. Ultrasonographic Detection of Metastatic Axillary Lymph Nodes in Breast Cancer / M.Nishida et al. / p316~316
  • General Lecture 236. Not Received / /
  • General Lecture 237. Successful Imaging of Lung Cancers by a Radiolabeled Monoclonal Antibody / T.Okabe et al. / p316~316
  • General Lecture 238. Experimental Study of Tumor Detection Using¹³¹Labeled F(ab')₂ Fragments of Monoclonal Antibodies to CA 19-9 and CEA(IMACIS-1) / N.Mitsuhashi et al. / p316~316
  • General Lecture 239. Clinical Evaluation of Immunoscintigraphy Useing IMACIS-1 / T.Takahashi et al. / p317~317
  • General Lecture 240. Radioimmunoscintigraphy of Malignant Tumors Using a Cocktail of F(ab')₂ Fragments of Monoclonal Antibodies to CEA and CA19-9 with I-131(IMACIS-1) / A.Okazaki et al. / p317~317
  • General Lecture 241. Not Received / /
  • General Lecture 242. Daiagnosis of Depth Invasion in Gastric Cancer by Examination of Endoscopic Ultrasonography(EUS)and Operative Ultrasonography(OUS) / H.Hasegawa et al. / p317~317
  • General Lecture 243. The Evaluation of Angiography in Diagnosing the Peritoneal Dissemination of Gastrointesti- nal Cancer / Y.Shioaki et al. / p318~318
  • General Lecture 244. Preoperative Examinations for Esophageal and Rectal Cancer by MRI / T.Tsuda et al. / p318~318
  • General Lecture 245. Evaluation of the Effect of Lipiodol-associated Transcatheter Arterial Embolization(LpTAE)for Hepatocellular Carcinoma by Hepatic Angiography / M.Itsubo et al. / p318~318
  • General Lecture 246. Evaluation of the Continuous Intra-arterial Infusion Treatment for Hepatic Cancer by DSA / Y.Furukawa et al. / p319~318
  • General Lecture 247. Growth Rate of Small Hepatocellular Carcinoma by Computed Tomography / T.Sato et al. / p319~319
  • General Lecture 248. Subrenal Capsule Assay(SRC)Using Human Lung Cancer Xenograft and Tumor Tissues from Lung Cancer Patients / A.Tada et al. / p319~319
  • General Lecture 249. Chemosensitivity Test for Platinum Derivatives Using a Subrenal Capsule Assay / S.Kudoh et al. / p320~320
  • General Lecture 250. Analysis of the Chemo and Endocrine Sensitivity Test by Subrenal Capsule Assay for Breast Cancer / S.Kawamura et al. / p320~320
  • General Lecture 251. Preclinical Evaluation of a New Anthracycline Derivative, SM-5887 on the Subrenal Capsule Assay / H.Shibata et al. / p320~320
  • General Lecture 252. The Subrenal Capsule Assay(SRCA)as a Predictor of Tumor Response to Chemotherapy in Rats / E.Yokoyama et al. / p321~321
  • General Lecture 253. The Combination Effect of Caffeine and CDDP on Human Lung Cancer Cell Line / Y.Ohsaki et al. / p321~321
  • General Lecture 254. Not Received / /
  • General Lecture 255. A Study of the Effects of Anti-tumor Agents Combined with γ-interferon on an Established Cell Line of Human Maxillary Carcinoma and Human Tumor Xenografts Transplanted into Nude Mice / M.Miyata et al. / p321~321
  • General Lecture 256. Postoperative Adjuvant Chemotherapy for Advanced Gastric Cancer Based on the Succinate Dehydrogenase Inhibition (SDI) Test / T.Kusumoto et al. / p322~322
  • General Lecture 257. The Investigation of the Evaluable Rate in Succinate Dehydrogenase Inhibition Test(SDI Test)for in vitro Chemosensitivity Test / Y.Kirihara et al. / p322~322
  • General Lecture 258. Studies of Cell Killing Effects of PDT Using Adriamycin and Hematoporphyrin Derivative on Cultured Human Bladder Cancer Cells,KK-47 / M.Nitta et al. / p322~322
  • General Lecture 259. MTT Assay as a Chemosensitivity Test / A.Suto et al. / p323~323
  • General Lecture 260. Clinical Evaluation of Cisplatin(CDDP)for Malignant Glioma / T.Hotta et al. / p323~323
  • General Lecture 261. Effect of Chemotherapy Combined ACNU and VP-16 / K.Nomura et al. / p323~323
  • General Lecture 262. Effectiveness of Combination Therapy with Cisplatin and Etoposide for Malignant Brain Tumors / J.Yoshida et al. / p324~324
  • General Lecture 263. Combination Chemotherapy with Cyclophosphamide(C),Vincristine(V)and Dacarbazine(D)in Patients with Malignant Pheochromocytoma / T.Tsuchihashi et al. / p324~324
  • General Lecture 264. An effective Combination Chemotherapy(P-CAV)for Advanced Skin Cancer / S.Yanagawa et al. / p324~324
  • General Lecture 265 Clinico-pathological Studies on Effects of Induction Chemotherapy in Squamous Cell Carcinoma of Gingiva / H.Sunakawa et al. / p325~325
  • General Lecture 266. Chemotherapy of Head and Neck Squamous Cell Cancer / M.Uchida et al. / p325~325
  • General Lecture 267. Combination Chemotherapy with Cisplatin,Peplomycin and Methotrexate(CPM)for Advanced Head and Neck Carcinoma / I.Tsushin.i et ai. / p325~325
  • General Lecture 268. Combination Chemotherapy with Adriamycin,Cisplatin and Peplomycin on Head and Neck Cancer / H.Hosoda et al. / p326~326
  • General Lecture 269. Multi-drug Combination Therapy of Cancer of the Head and Neck Using Cisplatin as the Basic Agent / T.Furusaka et al. / p326~326
  • General Lecture 270. A study on Multi-drug Combination Chemotherapy Including Cisplatin(CDDP)in Cancer of Head and Neck / T.Takaoka et al. / p326~326
  • General Lecture 271. Non-cross-resistance in the Chemotherapy of Head and Neck Cancer / M.Toji et al. / p327~327
  • General Lecture 272. Not Received / /
  • General Lecture 273. Treatment of Squamous Cell Carcinoma of the Head and Neck(H&N)Using Combination Chemotherapy with Vincristine(VCR), Methotrexate(MTX),Bleomycin(BLM)and Mitomycin-C(MMC),"BOMM" / N.Kohno et al. / p327~327
  • General Lecture 274. A Study of Second Line Chemotherapy for CDDP-PEP Combination Therapy / M.Kawaura et al. / p327~327
  • General Lecture 275. Sequential MTX/5FU Therapy for Advanced Gastric Cancer / T.Konishi et al. / p328~328
  • General Lecture 276. Methotrexate-5-fluorouracil-leucovorin Therapy in Patients with Advanced Gastric Cancer / Y.Ono et al. / p328~328
  • General Lecture 277. Sequential Methotrexate• 5FU Therapy for Advanced Gastric Cancer / M.Kitamura et al. / p328~328
  • General Lecture 278. Combination Therapy of CDDP and MTX.5-FU Sequential Therapy for Gastroenteral Cancers / S.Ohyama et al. / p329~329
  • General Lecture 279. Sequential Methotrexate and 5-fluorouracil for Advanced Colorectal Cancer / S.Yasuda et al. / p329~329
  • General Lecture 280. Joint Study on Chemoendocrine Therapy for Gastric Cancer of the Borrmann IV Type in the Tochigi Prefecture,Japan / K.Kanazawa / p329~329
  • General Lecture 281. Randamized-controlled Study of Treatment with UFT-MMC or UFT-ACR for Advanced Gastric Cancer / J.Satoh et al. / p330~330
  • General Lecture 282. Not Received / /
  • General Lecture 283. A 4-year Surviving Case of Borrmann 2 Gastric Cancer Remarkably Improved by MF(Mitomycin C and 5-FU)Therapy / Y.Watanabe et al. / p330~330
  • General Lecture 284. A Case of Unresectable Gastric Cancer for which a Regimen Containing Lentinan,Mytomycin C and Tegafur was very Effective / A.Sano et al. / p330~330
  • General Lecture 285. A Multi-Institutional Study on Postoperative Adjuvant Chemotherapy for Cancer of the Stomach / S.Arima et al. / p331~331
  • General Lecture 286. Adjuvant Mitomycin-C(MMC)Prolongs Survival Time of Patients Undergoing Curative Surgery for Stage IV Gastric Cancer / D.Korenaga et al. / p331~331
  • General Lecture 287. Study of Post-operative Immunochemotherapy in Gastric Cancer / S.Sato et al. / p331~331
  • General Lecture 288. Postoperative Adjubant Chemotherapy for Gastric Cancer / T.Yamada et al. / p332~332
  • General Lecture 289. Study on the Period of Postoperative Chemotherapy for Gastric Cancer / S.Suzuki et al. / p332~332
  • General Lecture 290. 29pmN A Study of Postoperative Adjuvant Chemotherapy Using UFT in Cases who Had Undergone Curative Resection for Gastric Cancer / T.Kitoh et al. / p332~332
  • General Lecture 291. Postoperative Adjuvant Chemotherapy with NCS(Neocarzinostatin)and 5FU for Treatment of Gastric Cancer / T.Yokomori et al. / p333~333
  • General Lecture 292. Randomized Controlled Study between 5'-DFUR+ACNU and 5'-DFUR+ACNU+MMC in Advanced Gastric Cancer / E.Fukuyama et al. / p333~333
  • General Lecture 293. Combination Chemotherapy with UFT• Etoposide• CDDP• Adriamycin(FEPA)in Advanced Gastric Cancer / M.Hayakawa et al. / p333~333
  • General Lecture 294. Chemotherapy of Advanced Gastric Cancer--UFT-M vs UFT/CDDP / H.Nagai et al. / p334~334
  • General Lecture 295. A Phase II Study of 5 days Continuous Infusion of 5-FU against Advanced Gastric Cancer / K.Miyamoto et al. / p334~334
  • General Lecture 296. Experimental and Clincal Study of 5-fluorouracil-high Dose Leucovorin Combination / T.Sasaki et al. / p334~334
  • General Lecture 297. The Remarkable Effects of Immunochemotherapy by FT207 Added to OK 432 for the End stage of Gastric Cancer
  • A Case Report / M.Kiriyama et al. / p335~335
  • General Lecture 298. Influence of Gastrectomy on Absorption of Oral Pyrimidine Fluoride / T.Sato et al. / p335~335
  • General Lecture 299. Cytochrome P-450 and Postoperative Chemotherapy in Gastric Cancer / H.Watanabe et al. / p335~335
  • General Lecture 300. Effect of Angiotensin II-Induced Hypertension Chemotherapy against Recurrent and Advanced Gastric Cancer in Senile Patients / M.Satoh et al. / p336~336
  • General Lecture 301. Clinical and Pathohistological Patterns of Improvement in Advanced Gastric Carcinoma after AngiotensinII induced Hypertension Chemotherapy(IHC) / H.Sato et al. / p336~336
  • General Lecture 302. Effect of Angiotensin II-Induced Hypertension Chemotherapy in Advanced Pancreatic Cancer / M.Kimura et al. / p336~336
  • General Lecture 303. Hypertension Two-route Chemotherapy for Human Intraperitoneal Cancer / R.Abe et al. / p337~337
  • General Lecture 304. Holter Monitoring of Patient Receiving Induced Hypertension Chemotherapy / K.Okuma et al. / p337~337
  • General Lecture 305. Inhibition of Thymidylate Synthase in Lung Cancer Tissue after Administration of UFT / H.Wada et al. / p337~337
  • General Lecture 306. dTMP Synthase Activity in Cancer Cells / Y.Hashimoto et al. / p338~338
  • General Lecture 307. Study of Thymidylate Synthase Inhibitory Rate(TSIR)after Oral Treatment of Gastric Cancer Patients with 5-Fu / K.Namatame et al. / p338~338
  • General Lecture 308. Study on the Pharmacokinetics of UFT in the Hepatocellular Carcinoma Patients Associated with Cirrhosis / Y.Une et al. / p338~338
  • General Lecture 309. Not Received / /
  • General Lecture 310. Results of Combination Chemotherapy for Advanced Urothelial Cancer / S.Komatsubara et al. / p339~339
  • General Lecture 311. Results of M-VAC(Methotrexate,Vinblastine,Doxorubicin and Cisplatin) for Advanced Carcinoma of the Urothelium / M.Igawa et al. / p339~339
  • General Lecture 312. Experience of M-VAC Chemotherapy for Cancer of the Urogenital Tract / S.Sai et al. / p339~339
  • General Lecture 313. The Combination Chemotherapy of MTX, VBL, ADM and CDDP for Advanced Urothelial Cancer / T.Takeuchi et al. / p340~340
  • General Lecture 314. Clinical Evaluation of M-VAC Chemotherapy for Advanced Urothelial Cancer / S.Kameyama et al. / p340~340
  • General Lecture 315. Not Received / /
  • General Lecture 316. Treatment of Advanced Bladder Cancer / T.Ushiyama et al. / p340~340
  • General Lecture 317. Clinical Study on Effectiveness of Combination Chemotherapy with CDDP for Ovarian Cancer / A.Takahashi et al. / p341~341
  • General Lecture 318. Prognosis of Ovarian Cancer Treated with or without Cl. splatin(CDDP) / N.Usui et al. / p341~341
  • General Lecture 319. Not Received / /
  • General Lecture 320. Second-line Chemotherapy for Recurrent Ovarian Cancers Primarily Treated with Cyclophos-phamide,Adriamycin and Cisplatine(CAP) / H.Yokota et al. / p341~341
  • General Lecture 321. The Treatment of far Advanced Cancer Patients with Massive Ascites / M.Hirono et al. / p342~342
  • General Lecture 322. Clinical Studies on the Efficacy Of Maintenance Chemotherapy for Patients with Ovarian Cancer / K.Takakuwa et al. / p342~342
  • General Lecture 323. A Study of 49 Ovarian Cancer Patients Administered CDDP-ip / M.Maruyama et al. / p342~342
  • General Lecture 324. Effect of Intraperitorieal Administration of CDDP,Anticoagulatory,Antiplasmin and Anti-thrombinIII on Recurrent Ovarian Cancer / H.Suzuki et al. / p343~343
  • General Lecture 325. Effects of Remission Induction Chemotherapy on Blood Coagulability in Patients with Gynecological Malignancies / K.Sawaguchi et al. / p343~343
  • General Lecture 326. Blood Coagulability Changes in Patients with Advanced Gynecological Malignancies under Remission Induction Chemotherapy / K.Tomiura et al. / p343~343
  • General Lecture 327. Evaluation of Total Parenteral Nutrition(TPN)Using Imbalanced Aminoacids Solution in Chemotherapy for Ovarian Cancer / M.Sato et al. / p344~344
  • General Lecture 328. Clinical Evaluation of Adjuvant Postoperative Chemotherapy following Radical Hysterectomy for Carcinoma of the Uterine Cervix / N.Matsuo et al. / p344~344
  • General Lecture 329. Adjuvant Chemotherapy for Uterine Cervical Cancer by Cooperative Group Study(II) Cooperative Study Group of Chemotherapy for Gynecological Cancer / H.Sugimori / p344~344
  • General Lecture 330. Adjuvant Chemotherapy and Radiotherapy in Patients with Cervical Cancer at High Risk Recurrent Group after Radical Hystrectomy(Pilot study) / H.Dozono et al. / p345~345
  • General Lecture 331. Cisplatin,Ifosfamide and Doxorubicin Chemotherapy for Recurrent Cervical Cancer of the Uterus / T.Arimatsu et al. / p345~345
  • General Lecture 332. A Study of Continuous Peplomycin Infusion Therapy in Progressive Recurrent Gynecological Cancer / A.Uematsu et al. / p345~345
  • General Lecture 333. Effects Use of the PAE Method to stage III Ovarian Embryonal Carcinoma / K.Murayama et al. / p346~346
  • General Lecture 334. Efficancy of Regimen Containing CDDP on Ovarian Malignant Mixed Mesodermal Tumor / S.Hino et al. / p346~346
  • General Lecture 335. Promising Results of Cisplatin,Ifosfamide and Doxorubicin for Grade 3 Endometrial Cancer / T.Matsuzaki et al. / p346~346
  • General Lecture 336. Combined Chemotherapy with CDDP and Vindesine for Uterine Cervical Adenocarcinoma and Endometrial Carcinoma / Y.Ihara et al. / p347~347
  • General Lecture 337. Efficacy of Adjuvant Chemotherapy by CDDP on Uterine Sarcoma / J.Nishida et al. / p347~347
  • General Lecture 338. A Successful Case with High-dose Cisplatinum for Adenocarcinoma of the Vulva / A.Arakawa et al. / p347~347
  • General Lecture 339. Effect of High-dose Chemotherapy with Autologous Bone Marrow Transplantation in Malignant Ovarian Tumor / M.Murakami et al. / p348~348
  • General Lecture 340. High dose Chemotherapy and Autologous Bone Marrow Transplantation for Advanced Testicular Cancer / H.Ishii et al. / p348~348
  • General Lecture 341. High dose Chemotherapy with Autologous Bone Marrow Transplant for Patient with Advanced Testicular Cancer / N.Deguchi et al. / p348~348
  • General Lecture 342. High-dose Chemotherapy Supported by Autologous Bone Marrow Transplantation in Advanced Cancers / M.Kasai et al. / p349~349
  • General Lecture 343. Review on Efficacy of Autologous Bone Marrow Transplantation for Bone Marrow Depression after High Dose Chemotherapy / S.Tsuchiya et al. / p349~349
  • General Lecture 344. Supportive Therapy of Cancer Chemotherapy with Use of Peripheral Blood Stem Cell Transplantation / K.Sampi et al. / p349~349
  • General Lecture 345. Effectiveness of Ubenimex in Preventing Bone Marrow Suppression Caused by Chemotherapy / K.Komuta et al. / p350~350
  • General Lecture 346. A Combination Therapy of PSK and Cephalantin for the MDS Patients / Y.Kobayashi et al. / p350~350
  • General Lecture 347. Effects of Cepharanthin on Chemotherapy-induced Leukopenia / K.Asukai et al. / p350~350
  • General Lecture 348. Restorative Effect of Muroctasin,MDP-Lys(L-18),on Leukopenia by Anticancer Chemother-apy in Lung Cancer--Comparative Study by Envelop Method / M.Takada et al. / p351~351
  • General Lecture 349. The Recoverable Effect of Lentinus Edodes(LNT)from Granulocytopenia after Chemotherapy for Gynecologic Malignancies / S.Takeshita et al. / p351~351
  • General Lecture 350. Stimulatory Effect of Glycyrrhizin on CFU-C Colony Formation from Human Bone Marrow Cells in vitro / F.Omori et al. / p351~351
  • General Lecture 351. Phase I/II Study of KRN 8601(Recombinant Human Granulocyte Colony Stimulating Factor,rhG-CSF)in the Combination Chemotherapy for Malignant Lung Tumours / H.Kunitoh et al. / p352~352
  • General Lecture 352. Effect of Combined Therapy with Sizofiran(SPG)and Irradiation on Patients with Cervical Cancer / M.Ohno et al. / p352~352
  • General Lecture 353. Not Received / /
  • General Lecture 354. Changes in Lymphocyte Subsets and ADCC/NK Activities by Immunopotentiators(SPG,OK-432)in the Patients with Advanced Cervical Cancer / K.Hasegawa et al. / p352~352
  • General Lecture 355. Effects of Schizophyllan(SPG)on Immunological Parameters in Patients with Cervical Cancer during Radiotherapy / H.Yabushita et al. / p353~353
  • General Lecture 356. Effects of Combined Therapy with Sizofilan(SPG)and Irradiation on Cervical Cancer Patients / T.Imai et al. / p353~353
  • General Lecture 357. The Immunological Effect of Concomitant Use of Schizophyllan(SPG)on Advanced Uterine Cervical Cancer Treated with Radiation / O.Iwanari et al. / p353~353
  • General Lecture 358. Activation of Human Macrophage by SPG Injected Intramusclary / J.Tung Chen et al. / p354~354
  • General Lecture 359. Clinical Evaluation of Postoperative Adjuvant Immunochemotherapy with Sizofiran(SPG)for Resectable Gastric Cancer: A Randomized controlled study / S.Fujimoto et al. / p354~354
  • General Lecture 360. Clinical Evaluation of the Antitumor Polysaccharide SIZOFIRAN(SPG)in Advanced Gastric Cancer / I.Nakao et al. / p354~354
  • General Lecture 361. An immunological Study of Anti-tumor Polysaccharide(SPG:Sonifilan) for Oral Cancer by Two-color Analysis / S.Kikuchi et al. / p355~355
  • General Lecture 362. Effect of SPG for Neutrophilic Function / T.Nakayama et al. / p355~355
  • General Lecture 363. Immunotherapy of Terminal-stage Malignant Tumor with an Immunopotentiator Lentinan / S.Yagi et al. / p355~355
  • General Lecture 364. Immunological Evaluation of Intrapleural and/or Intraperitoneal Lentinan Therapy for Carcinomatous Pleuritis and Peritonitis / S.Yoshino et al. / p356~356
  • General Lecture 365. Nutritional Supplementation of Elemental Diet and Immunochemotherapy with Lentinan in 4 Cases / O.Soeda et al. / p356~356
  • General Lecture 366. Change of Blood Lentinan Level in Long Term Course / Y.Yajima et al. / p356~356
  • General Lecture 367. Successful Therapy with Tegafur and Lentinan for Hepatocellular Carcinoma--A Case Report / K.Miyamoto et al / p357~357
  • General Lecture 368. Evaluation of BRM Therapy on Immunostatus in Patients with Head and Neck Cancer / T.Yoshida et al. / p357~357
  • General Lecture 369. Augmentation of Natural Killer(NK)Activity and Prevention of Chemotherapy-induced Leukocytopenia by Lentinan / H.Shimizu et al. / p357~357
  • General Lecture 370. The Influence of Lentinan on Postoperative Cellular Immunosupression in Gastric Cancer / T.Momiyama et al. / p358~358
  • General Lecture 371. Endoscopic Local Injection of Lentinan in the Patients with Gastric Cancer / K.Morise et al. / p358~358
  • General Lecture 372. A Study of Immunotherapy in Advanced Agers' Gastric Cancer(Part 1) / T.Gotoh et al. / p358~358
  • General Lecture 373. Influence of Peritumoral Injection of Lentinan on the Local and Systemic Lymphocytic Subsets in Patients with Gastric Cancer / Y.Obi et al. / p359~359
  • General Lecture 374. Effect of Administration of Lentinan on Rabbit IgG Binding Fc-receptor of Monocytes in Patients with Gastric Cancer / T.Kitahora et al. / p359~359
  • General Lecture 375. Effect of Lentinan on Natural Killer Activities in Patients with Gastric Carcinoma at Early stage / H.Yamanishi et al. / p359~359
  • General Lecture 376. Clinical and Pathological Review of Malignant Lymphoma at Autopsy / Y.Tamaki et al. / p360~360
  • General Lecture 377. Two Cases of Primary Orbital Malignant Lymphoma / M.Kojima et al. / p360~360
  • General Lecture 378. A Case Report of the Gastric Malignant Lymphoma with Early Gastric Cancer / A.Takeda et al. / p360~360
  • General Lecture 379. Clinical Features of AILD as a Prelymphomatous Lesion / T.Kobayashi et al. / p361~361
  • General Lecture 380. Polymorphic Reticulosis of the Larynx Diagnosesed as T Cell Lymphoma by Autopsied Laryngeal Specimen / T.Nakashima et al. / p361~361
  • General Lecture 381. Two Cases of Thyroid Medullary Carcinoma / H.Nishino et al. / p361~361
  • General Lecture 382. Clinical Study on Malignant Transformed Papilloma / M.Ida et al. / p362~362
  • General Lecture 383. Study of a Case with Cancerization in the Gastric Atypical Epithelial Lesion / M.Eriguchi et al. / p362~362
  • General Lecture 384. A 37-year-Old Man with Primary Carcinoma Jejunum / T.Hattori et al. / p362~362
  • General Lecture 385. A Case of Hepatocelluar Carcinoma(HCC)within Adenomatous Hyperplasia in Liver / T.Urushihara et al. / p363~363
  • General Lecture 386. Application of Endoscopic Retrograde Bile Drainage(ERBD)and Lenthinan to the Treat-ment of the Cancer in Common Hepatic Bile Duct Accompanied by the Anomolous Arrangement of the Pancreatico Biliary Ductal System / A.Murakami et al. / p363~363
  • General Lecture 387. Examination of Adrenocortical Carcinoma Experienced by Our Department / H.Nozaki et al. / p363~363
  • General Lecture 388. Cases detected by Neuroblastoma Mass Screening Test in Our Department / K.Sue et al. / p364~364
  • General Lecture 389. Four Cases of Oral Cancer which Followed Unusual Clinical Courses / B.Satake et al. / p364~364
  • General Lecture 390. Basic Study on Excimer Dye Laser in Gynecology / T.Sugishita et al. / p364~364
  • General Lecture 391. Improvement of the Operative Technique in Laser Vaporization Therapy of Cervical Intraepithelial Neoplasia / H.Kanou et al. / p365~365
  • General Lecture 392. Contact Nd. YAG Laser Treatment for early Cervical Neoplasia--Significance of Preoperative Diagnosis and Countermeasures against Incomplete Excision / K.Kitsuki et al. / p365~365
  • General Lecture 393. The Study on Residual Lesion after CO2 Laser Conization for Cervical Intraepiterial Neoplasia / J.Miyako et al. / p365~365
  • General Lecture 394. Integral Laser-phtodynamic Treatment of Bladder Tumors Using Hematoporphyrin Derivative / K.Naito et al. / p366~366
  • General Lecture 395. Combination of Photoradiation Therapy with Chemotherapy Using Adriamycin for Advanced Breast Cancer / H.Hirakawa et al. / p366~366
  • General Lecture 396. The Effectiveness of Photodynamic Therapy(PDT)with Hematoporhyrin Derivative(HpD)for Roentgenographically Occult lung Cancer / K.Furuse et al. / p366~366
  • General Lecture 397. Clinical Evaluation of Direct Current Therapy with Chemotherapy in Lesional Treatment of Malignant Tumors / Y.Matsushima et al. / p367~367
  • General Lecture 398. The Evaluation of the Effect of High Energy Shock Wave on Tumor / K.Kohri et al. / p367~367
  • General Lecture 399. Enhancement of Cell Killing Effect of Ultrasound by Photosensitizer / K.Umemuta et al. / p367~367
  • General Lecture 400. Cytotoxic Effects of Photoexcited TiO2 Semiconductor Colloid on Human Cancer Cells / M.Masuda et al. / p368~368
  • General Lecture 401. Studies on Laserthermia and Photodynamic Therapy(PDT)Using Nd:YAG Laser / H.Tsunekawa et al. / p368~368
  • General Lecture 402. Immunohistochemical Study of Ras p21 in Gastric Cancer / K.Sugiyama et al. / p368~368
  • General Lecture 403. Expression of Oncogenes in Colorectal Cancer / N.Hara et al. / p369~369
  • General Lecture 404. Immunohistochemical Evaluation of Ras and Myc Oncogene Expression in Ovarian Carcinomas / H.Matsuda et al. / p369~369
  • General Lecture 405. Detection of Human Papillomavirus(HPV)DNA and E₆/E₇mRNA in the Precancerous Lesions of Uterine Cervix / N.Nagai et al. / p369~369
  • General Lecture 406. Relations between the Follow up Results of Cervical Dysplasia and Immunohistochemical Findings on Human Papilloma Virus(HPV)Infection / M.Sato et al. / p370~370
  • General Lecture 407. Clinical Evaluation of Presence of EGF Receptors(EGFR)in Human Esophageal Carcinomas / G.Shirozu et al. / p370~370
  • General Lecture 408. EGF and EGFR status in Borrmann 4 type Gastric Carcinoma / S.Fushida et al. / p370~370
  • General Lecture 409. Investigation of the Precancerous Lesion of the Thyroid Tumors Using EGF-R / H.Masuda et al. / p371~371
  • General Lecture 410. Anti-tumor Effect of EGF(Epidermal growth factor)on Human Breast Cancer Transplanted in Nude Mice / Y.Murayama et al. / p371~371
  • General Lecture 411. Emergence of Epidermal Growth Factor and Its Receptor in Endometrial Carcinoma under the Influence of Progestin / Y.Yokoyama et al. / p371~371
  • General Lecture 412. Clinical Study on EGF Concentration in Urine and Tissue EGF Receptor in Patients with Bladder Cancer / T.Fujioka et al. / p372~372
  • General Lecture 413. Effect of Epidermal Growth Factor(EGF)on the Growth of Squamous Cell Carcinoma of Bladder(SCaB) / T.Hattori et al. / p372~372
  • General Lecture 414. An Evaluation of Neck Dissection in Tongue Cancer / S.Makino et al. / p372~372
  • General Lecture 415. Clinical Evaluation of Radical Neck Dissection in Oral Squamous Cell Carcinoma / S.Okabe et al. / p373~373
  • General Lecture 416. Investigation on Patients Undergoing Neck Dissection at Our Clinic / N.Akazawa et al. / p373~373
  • General Lecture 417. Clinical Study of the Patients who Underwent Enucleation or Partial Resection for Thyroid Cancer / M.Fujimori et al. / p373~373
  • General Lecture 418. Not Received / /
  • General Lecture 419. Pathological Studies on Rectal Cancer Treated with Preoperative Irradiation and Anticancered Suppositary / J.Itoh et al. / p374~374
  • General Lecture 420. Preoperative Combined Therapy for Rectal Cancer by Radiation and 5-Fluorouracil Suppository / M.Niwa et al. / p374~374
  • General Lecture 421. Pre-and Intra-operative Radiotherapy for rrctal Cancer--Clinical Evaluation of Its Complications / Y.Otashiro et al. / p374~374
  • General Lecture 422. High-dose-rate Afterloading Intracavitary Irradiation and Expandable Biliary Endoprosthesis for Malignant Biliary Obstruction / H.Yoshimura et al. / p375~375
  • General Lecture 423. Chemotherapy with Chest Radiotherapy in Limited Disease of Small Cell Lung Carcinoma / T.Soejima et al. / p375~375
  • General Lecture 424. Combined Treatment of Radiation and Chemotherapy for Lung Cancers / K.Ono et al. / p375~375
  • General Lecture 425. Clinical Study on Radiosensitization of Aclarubincin / T.Miyamoto et al. / p376~376
  • General Lecture 426. Clinical Application of MFD(Multiple Fractions Per Day)for Non-oat Cell Carcinoma of the Lung / Y.Kikuchi et al. / p376~376
  • General Lecture 427. The Prognosis According to New Clinical TNM Staging of Lung Cancer Treated with Radiation Therapy / K.Hayaakawa et al. / p376~376
  • General Lecture 428. Characrerization of the Long Cancer Patients who Received Radiation Therapy and Survived for a Long Time--Special Reference to the Analysis of Peripheral Blood Lymphocyte Subsets and Tumor Infiltrated Lymphocytes / T.Inomata et al. / p377~377
  • General Lecture 429. Study of Prognostic Factors fbr Patients with Limited Non-small Cell Lung Cancer / K.Yonezawa et al. / p377~377
  • General Lecture 430. Conservative Treatment for Early Breast Cancer--Study at T.W.M.C / M.Kitaet al. / p377~377
  • General Lecture 431. Significance of Postoperative Radiotherapy for Breast Cancer / T.Yanagisawa et al. / p378~378
  • General Lecture 432. The Effectiveness of Radiation Therapy for Bone Metastasis from Breast Cancer / M.Kawashima et al. / p378~378
  • General Lecture 433. Radiation Therapy for Metastatic Bone Tumors / Y.Nagata et al. / p378~378
  • General Lecture 434. The Effect of Radioiodine Treatment for Thyroid Carcinoma with Tracheal Invasion / M.Katagiri et al. / p379~379
  • General Lecture 435. Radiotherapy for the Tracheo-bronchial Recurrence of the Esophageal Cancer after Surgery / T.Ogino et al. / p379~379
  • General Lecture 436. The Combined Treatment of Radiation and Cisplatin for Esophageal Cancer / A.Takamura et al. / p379~379
  • General Lecture 437. Combination Therapy with Radiation and CDDP for Carcinoma of Esophagus Results of Clinical in 40 Radiation Facieities in Japan / T.Ishiskawa et al. / p380~380
  • General Lecture 438. Multi-axis and Over Centerable Conformation Radiotherapy for Esophageal Cancer / T.Mamiya et al. / p380~380
  • General Lecture 439. Application of Multiple Fractions per Day(MFD)to Esophageal Carcinoma / S.Nishino et al. / p380~380
  • General Lecture 440. High-dose-rate Intracavitary Irradiation for Esophageal Carcinoma Combined with External Irradiation / H.Fukuda et al. / p381~381
  • General Lecture 441. Clinical Experience with Intraoperative Radiotherapy in Cases of Esophageal Carcinoma / Y.Ozawa et al. / p381~381
  • General Lecture 442. Not Received / /
  • General Lecture 443. Anti-tumor Effects of Intraperitoneal Injection of Recombinant Interleukin 2 / K.Shiiba et al. / p381~381
  • General Lecture 444. Prediction of Effect of Immunotherapy of Cancer and Its Clinical Correlation / K.Takahashi et al. / p382~381
  • General Lecture 445. A Clinical Trial of Lentinan and Interleukin-2 Combination Therapy in the Treatment of Primary Hepatocellular Carcinoma Patients / H.Matsuda et al. / p382~382
  • General Lecture 446. Not Received / /
  • General Lecture 447. Phase II Study of Combination Therapy with rIL2 and IFN-beta / T.Tamura et al. / p382~382
  • General Lecture 448. Clinical Evaluation of Intrapleural Adoministation of IL-2 for the Patients Diagnosed as Pleuritis Carcinomatosa / M.Negishi et al. / p383~383
  • General Lecture 449. Enhancement of Cytotoxic Activity of Mediastinal Lymphnodes by Trans-tracheal Injection to the Subcarinal Lymphnode of Recombinant Interleukin-2(rIL-2) / K.Tani et al. / p383~383
  • General Lecture 450. The Immunological Modulation of Malignant Lymphoma Patients by Interferon-α / H.Yamaue et al. / p383~383
  • General Lecture 451. Effect of Intraperitoneally Administered OK 432 Followed by Intraperitoneal rIL-2(Recombinant Interleukin 2)on Peritonitis Carcinomatosa / Y.Kanaoka et al. / p384~384
  • General Lecture 452. Postoperative Adjuvant Therapy of Renal Cell Carcinoma with α-interferon (Preliminary Report) / Y.Satomi et al. / p384~384
  • General Lecture 453. Clinical Study of Interferon-α Therapy for Patients with Advanced Renal Cell Carcinoma / T.Murai et al. / p384~384
  • General Lecture 454. Effect of AS Vaccinia Virus for Advanced Cancer / T.Matsui et al. / p385~385
  • General Lecture 455. Study on Immuno-competence of Peripheral Blood and Regional Lymph Nodes in Patients with Breast Cancer--Influence of Preoperative Adminisration of Immuno-Activators / H.Takahashi et al. / p385~385
  • General Lecture 456. Clinical Effect of PSK on Esophageal Cancer as an Immunopotentiator (Second Report) / K.Ogoshi et al. / p385~385
  • General Lecture 457. An Adjuvant Immunochemotherapy for Gastric Cancer / A.Koike et al. / p386~386
  • General Lecture 458. Serum Immunosuppressive Substance(IS)and Effects of Biological Response Modifier,PSK on Urogenital Tumors / K.Ikeda et al. / p386~386
  • General Lecture 459. Study on Evaluation of Immunochemotherapy to Prevent the Recurrence of Bladder Cancer / Y.Nakagami et al. / p386~386
  • General Lecture 460. Evaluation of Postoperative Immunochemotherapy(VCR,MMC,MTX)for Lung Cancer Patients / T.Ikeda et al. / p387~387
  • General Lecture 461. Clinical Evaluation of the Postoperative Immunochemotherapy for Gastric Cancer / M.Shiraishi et al. / p387~387
  • General Lecture 462. Evaluation of Immuno-chemotherapy for Non-curative,Non-resectable Gastric Cancer Patients / Y.Kondoet al. / p387~387
  • General Lecture 463. Evaluation of Immuno-chemotherapy for Non-curative and Non-resectable Colorectal Cancer / O.Nishida et al. / p388~388
  • General Lecture 464. Clinical and Experimental Study on Oral Administration of "OK-432" / M.Abe et al. / p388~388
  • General Lecture 465. Controlled Trial of Postoperative Adjuvant Chemotherapy with OK-432 for Advanced Colorectal Cancer / Y.Horita et al. / p388~388
  • General Lecture 466. The Study of the Optimal Therapeutic Protocol of OK-432 by Sequential Kinetics of the Various Immunological Parameter / S.Fujieda et al. / p389~389
  • General Lecture 467. Immunoactivity of Patients with Hepatoma Injected OK-432:Comparison between These with Splenic Arterial Injection and Systemic Venous Injection / T¡Hihara et al. / p389~389
  • General Lecture 468. Immunotherapy of Terminal-stage Malignant Tumors with an Immunopotentiator OK-432 and Lentinan / Y.Yagi et al. / p389~389
  • General Lecture 469. 3 Case of Cervical Cancer with Long Survival(More than 5 yrs)by Administration of OK-432 / R.Nakamura et al. / p390~390
  • General Lecture 470. A Study of the Immunoactivity of Ovarian Cancer Patients with or without OK 432 Treatment / S.Itoh et al. / p390~390
  • General Lecture 471. A Case of Ovarian Cancer Induced to Complete Remission by i.p.Injection of OK-432 and Chemotherapy / H.Kato et al. / p390~390
  • General Lecture 472. Immunological Effects of OK 432 Administration in Cervical Cancer Patients--Suppressor T Cell(CD8₊₊11₊),Killer T Cell(CD8₊₊1₋)and Con.A.induced Suppressor Cell Activity / M.Mizuno et al. / p391~391
  • General Lecture 473. Induction of Tumor Necrosis Factor(TNF)and Interferon-γ(IFN一γ)by OK-432 in Renal Cancer Patients / K.Kumagai et al. / p391~391
  • General Lecture 474. Effect of OK 432 on Advanced Gastric Cancer / M.Fujii et al. / p391~391
  • General Lecture 475. Effect of Preoperative Intra-tumoral Injection of OK-432 to Gastric Cancer(The 2nd Report) / A.Gohchi et al. / p392~392
  • General Lecture 476. Combination Chemoimmunotherapy with MMC and OK 432 for Gastric Carcinoma / S.Arinaga et al. / p392~392
  • General Lecture 477. Study of Postoperative Su-PS Skin Reaction in Pacients with Gastric Cancer With Special Reference to the Relation with Prognosis / T.Ogawaet al. / p392~392
  • General Lecture 478. Effect of OK-432 on the Cellular Immunological Competence of Patients with Stomach Cancer / T.Hirose et al. / p393~393
  • General Lecture 479. Not Received / /
  • General Lecture 480. Augmentation of Immunological Reactivities of Regional Lymph Node Lymphocytes by OK-432 in Gastric Cancer Patients:Comparison between the Effects of Intratumoral Injection and Those of Oral Administration / EYanagawa et al. / p393~393
  • General Lecture 481. Preventive Effect of Bithmus Subnitrate on Toxicity by CDDP / M.Ogawara et al. / p393~393
  • General Lecture 483. Bismuth Subnitrate, Clinical Studies for Reducing Effects on Cisplatin Toxicities / T.Morikawa et al. / p394~394
  • General Lecture 484. The Effect of Bismuth Subnitrate for Pharmacokinetics and Side Reactions of Cisplatin in Patients of Gynecological Cancer / H.Hirayama et al. / p394~394
  • General Lecture 485. Side Effects of High Dose Cisplatin / M.Sakugawa et al. / p394~394
  • General Lecture 486. Effects of Carboplatin on the Renal Function / Y.Yasui et al. / p395~395
  • General Lecture 487. Clinical Studies of CDDP Nephrotoxicity--Comparison with Intravenous,Intra-arterial and Intra-peritoneal Methods / E.Ito et al. / p395~395
  • General Lecture 488. Renal Tubular Damage Associated with Cisplatin Nephrotoxicity / K.Higuchi et al. / p395~395
  • General Lecture 489. Intraperitoneal Chemotherapeutic Perfusion(IPCP)with Mitomycin C and Intraperitoneal Administration(IP)of the Carcinostatic Cocktail Including Cisplatin for Ovarial Cancer(O-C)--Clinical Study of Renal Failure after IPCP-IP Method / S.Yamashita et al. / p396~396
  • General Lecture 490. Effects of the Combined Use of Cisplatin(CDDP)and Ifosfamide(IFX)on Tubular Toxicity / A.Fujita et al. / p396~396
  • General Lecture 491. Prevention of Frey's Syndrome with an Island Temporalis Fascial Flap--A Preliminary Report / T.Kaneko et al. / p396~396
  • General Lecture 492. The Reconstruction of 80 Head and Neck Cancer Patients with Free Rectus Abdominis Musculocutaneous Flaps / H.Asato et al. / p397~397
  • General Lecture 493. Not Received / /
  • General Lecture 494. Operative Therapy for Advanced or Recurrent Breast Cancer--Especially Using Pedicled Omental Flap and Mesh Skin Grafting / M.Yoshioka et al. / p397~397
  • General Lecture 495. Surgical Result of the Modified Radical Mastectomy(Auchincloss)for T2-breast Cancer / S.Oura et al. / p397~397
  • General Lecture 496. Reconstruction of Malignant Bone Tumor by Composite Graft of Biomaterial(Almina Ceramic/Dacron Fabric) / K.Shinjo et al. / p398~398
  • General Lecture 497. Urinary Diversion via a Continent Urinary Reservoir:Comparison between Indiana Pouch and Kock Pouch / Y.Okada et al. / p398~398
  • General Lecture 498. Anterior Pelvic Exentration with Vulvectomy for Advanced Female Urethral Carcinoma / T.Ito et al. / p398~398
  • General Lecture 499. Trial of the Preservation of the Bladder Function Following Radical Hysterectomy Using Neurostain and Functional Electric Stimulation / T.Hachisuga et al. / p399~399
  • General Lecture 500. Relationship of Operative Method of Rectal Cancer to Postoperative Urinary and Sexual Function / H.Naito et al. / p399~399
  • General Lecture 501. Male Sexual Function after Autonomic Nerve Preserving Operation for Rectal Cancer / K.Eguchi et al. / p399~399
  • General Lecture 502. Amelioration of Combination Chemotherapy with Cisplatin: Escalation of Total Dose and Improvement of Quality of Life in Patients with Ovarial Malignant Tumor / S.Isonishi et al. / p400~400
  • General Lecture 503. A Study of Evaluation of Side Effects in CAP Chemotherapy.--Cardiotoxicity Evaluated by Radionuclide LVEF and Ototoxicity by Audiogram / M.Yabuta et al. / p400~400
  • General Lecture 504. Complications of VAC Therapy / K.Sutou et al. / p400~400
  • General Lecture 505. Clinical Analysis on Side Effects of Maintenance Chemotherapy against Gynecological Malignant Tumors / T.Shimoda et al. / p401~401
  • General Lecture 506. A Case of Hypomagnesia and Refractory Cardiac Arrythmia Associated with Cisplatin Combination Therapy / H.Murata et al. / p401~401
  • General Lecture 507. Urinary β₂-microglobulin as Indicator of Impaired Excretion of Methotrexate / K.Amino et al. / p401~401
  • General Lecture 508. Anosmia Caused by Long-term Administration of Tegaful / K.Toda et al. / p402~402
  • General Lecture 509. Not Received / /
  • General Lecture 510. Double Blind Study on Preventive Efficacy of Mesna against Ifosfamide(IFO)Induced Urinary Disorders / M.Fukuoka et al. / p402~402
  • General Lecture 511. Clinical Efficacies of Mepitiostane as a Supportive Therapy in Chemotherapy for Breast and Lung Cancer / H.Yokoi et al. / p402~402
  • General Lecture 512. Prevention of Adriamycin-induced Alopecia by Scalp Hypothermia with a Deep-frozen Duncool-Cap / Y.Konishi et al. / p403~403
  • General Lecture 513. A Study of Septicemia in Cancer Patients / N.Tanabe et al. / p403~403
  • General Lecture 514. Immunostimulating Effect and Tumor Growth Inhibitory Effect of Panax Ginseng / M.Katano et al. / p403~403
  • General Lecture 515. Cancer Chemotherapy with Oriental Medicine(Second) / A.Sato et al. / p404~404
  • General Lecture 516. Role of Fine Needle Aspiration Cytology in Diagnosis of Breast Cancer / K.Hisamatsu et al. / p404~404
  • General Lecture 517. Clinical Studies on Diagnosis of Aspiration Cytology, Mammography and Ultrasound for Breast Carcinoma / H.Fukushima et al. / p404~404
  • General Lecture 518. In vivo Measurement of Electrical Bio-impedance of Breast Tumors / Y.Konishi et al. / p405~405
  • General Lecture 519. The Annual Trend and Problem Seen in the Mas Examination for the Breast Cancer / J.Amano et al. / p405~405
  • General Lecture 520. Mass Screening for Breast Cancer--The Results for 8 Years and Further Problems / T.Ishida et al. / p405~405
  • General Lecture 521. Mass Screening for Breast Cancer / J.Ota et al. / p406~406
  • General Lecture 522. The Mass Screening Campaign for Breast Cancer in Yokohama City, and the Study of Its Risk Factor / H.Yokoyama et al. / p406~406
  • General Lecture 523. Diagnosis and Treatment of Pre-cancer of stage of Esophagus / H.Makuuchi et al. / p406~406
  • General Lecture 524. The Study of Gastric Cancer Stroma on Biopsy / Y.Sonoda et al. / p407~407
  • General Lecture 525. Mass Screening for Colorectal Cancer by an Immunological Fecal Occult Blood Test / Y.Kumanishi et al. / p407~407
  • General Lecture 526. Not Received / /
  • General Lecture 527. Precancerous Lesions of Primary Hepatic Cancer:Its Diagnosis and Treatment / A.Harada et al. / p407~407
  • General Lecture 528. Diagnosis and Treatment for Precancerous Lesion of the Vocal Cord / G.Mizojiri et al. / p408~408
  • General Lecture 529. Experimental Evaluation of Adriamycin-containing Poly-L-lactic Acid Microspheres for P815 Tumor Cells / O.Ike et al. / p408~408
  • General Lecture 530. Antitumoric Effects with Sustained Release Implants of Anti-cancer Drugs / K.Matsumura et al. / p408~408
  • General Lecture 531. Experimental Study of Cisplatin-lipiodol Emulsion / Y.Hasegawa et al. / p409~409
  • General Lecture 532. Study of a Chemotherapeutic Method for Esophageal Cancer Enhanced Antitumor Effect of Peplomycin by Lipid-surfactant Mixed Micelles and a Macromolecular Dextran Sulfate / D.Kuroda et al. / p409~409
  • General Lecture 533. Transportation of MMC to Lymph-system by Means of Activated Charcoal / K.Ito et al. / p409~409
  • General Lecture 534. CDDP Chemotherapy in Combination with AngiotensinII Pressor for DMBA-induced Primary Ovarian Carcinoma / H.Higashijima et al. / p410~410
  • General Lecture 535. Not Received / /
  • General Lecture 536. ADM Bladder Instillation Therapy for Superficial Bladder Tumors / S.Nakagawa et al. / p410~410
  • General Lecture 537. Early Intravesical Instillation of Adriamycin(ADM)with Oral Administration of 5-fluorouracil(5-FU)after Transurethral Resection(TUR)for Superficial Bladder Cancer / T.Ueda et al. / p410~410
  • General Lecture 538. Evaluation of Prophylactic Intravesical Chemotherapy for Superficial Bladder Cancer Using Hazard Analysis / H.Akaza et al. / p411~411
  • General Lecture 539. Prophylactic Intravesical Instillation Therapy with Adriamycin and Mitomycin C in Patients with Superficial Bladder Cancer / J.Yoshimoto et al. / p411~411
  • General Lecture 540. Intravesical Instillation Therapy of Pepleomycin and Mitomycin C for Superficial Bladder Cancer / N.Sakakibara et al. / p411~411
  • General Lecture 541. Prophylactic Intravesical Chemotherapy in Patients with Superficial Bladder Tumors / H.Ito et al. / p412~412
  • General Lecture 542. Prophylactic Use of Mitomycin C Bladder Instillation for Preventing the Recurrence of Bladder Tumours / T.Mishina et al. / p412~412
  • General Lecture 543. Regional Hyperthermia in the Treatment of Uterine Cervical Cancer / M.Kinugasa et al. / p412~412
  • General Lecture 544. Treatment Results of Radiotherapy Combined with Hyperthermia Using 8MHz RF for the Advanced and Recurrent Cancer of the Uterine Cervix / Y.Ito et al. / p413~413
  • General Lecture 545. Case Reports:Remarkable Effect of Hyperthermia Combined with Irradiation on Metastatic Tumor of Uterine Cervical Cancer / J.Fujimoto et al. / p413~413
  • General Lecture 546. The Usefulness of Hyperthermia in the Cancer Treatment, Especially the Deep Hyperthermia for Gynecological Malignancies / Y.Kobashi et al. / p413~413
  • General Lecture 547. Clinical Effect of Hyperthermochemotherapy on Cervical and Ovarian Malignancies / M.Iwata et al. / p414~414
  • General Lecture 548. Clinical Results of Hyperthermic Therapy to Superficial and Deep Seated Tumor with BSD 1000 System / K.Hatano et al. / p414~414
  • General Lecture 549. Clinical Effects of Hyperthermia Treatment for Bladder Cancer / K.Ueda et al. / p414~414
  • General Lecture 550. Prostatic Hyperthermia by Using an Intraluminal Applicator / M.Hirai et al. / p415~415
  • General Lecture 551. Eight MHz RF-hyperthermia for Deep-seated Urological Malignancies / K.Nakajima et al. / p415~415
  • General Lecture 552. Studies of PPD and Su-PS Skin Tests and Lymphocyte Subsets in Patients with Advanced Urological Malignancies Treated with Hyperthermia / A.Nishino et al. / p415~415
  • General Lecture 553. Anti-Tumor Effect and Change of the Cell Cycle Treated by Hyperthermia and IFN Therapy (Fundamental and Clinical Studies) / M.Tada et al. / p416~416
  • General Lecture 554. Synergistic Effects of Hyperthermia and CDDP on Invasive Bladder Carcinoma in Mice / R.Noguchi et al. / p416~416
  • General Lecture 555. Not Received / /
  • General Lecture 556. The Effect of Intraperitoneal Lavage with MMC and OK-432 i.p Administration at Surgery for Peritoneal Dissemination of Advanced Gastric Cancer / T.Fujimoto et al. / p416~416
  • General Lecture 557. Topical Administration of Mitomycin C-dextran Conjugate(MMC-D)in Advanced Cancer Patients / K.Honda et al. / p417~417
  • General Lecture 558. Experimental and Clinical Evaluation of Local Treatment with Anticancer Drug-oil Suspension (Nimustine-Lipiodol Suspension) / S.Kobayashi et al. / p417~417
  • General Lecture 559. Percutaneous Intratumoral Injection Therapy of Lipiodol Containing Anticancer Drug / H.Aikawa et al. / p417~417
  • General Lecture 560. Therapy for Small Hepatocellular Carcinoma Using Intratumoral Injection of Apatite-Adriamycin Solution / A.Saito et al. / p418~418
  • General Lecture 561. Intrathecal Administration of ACNU fox Subarachnoid Dissemination of Malignant Tumor / M.Kochi et al. / p418~418
  • General Lecture 562. Intrathoracic Injection Therapy with Cisplatin(CDDP)-fibrinogen(FBG)for Cancerous Pleurisy / S.Takanashi et al. / p418~418
  • General Lecture 563. A New Therapy for Patients with Serious Pleuritis Carcinomatosa--Bio-Adhesio-Chemo(BAC)Therapy / K.Kawahara et al. / p419~419
  • General Lecture 564. Treatment of Advanced Ascitic Ovarian Cancer with Cyclophosphamide,Adriamycin and Intraperitoneal Cisplatin / H.Taniguchi et al. / p419~419
  • General Lecture 565. Intraperitoneal Infusion Chemotherapy Using Implanted Reservoir to Advanced Ovarian Cancer / T.Yoshida et al. / p419~419
  • General Lecture 566. Topical CDDP Injection Therapy for Gynecologic Malignant Tumors which do not Allow Curative Excision / S.Sato et al. / p420~420
  • General Lecture 567. Not Received / /
  • General Lecture 568. Chemoembolization and Regional Hyperthermia with DSM(Degradable Starch Microspheres)in the Treatment of Malignant Hepatic Tumors / H.Ichikawa et al. / p420~420
  • General Lecture 569. Local Hyperthermai for Carcinoma of the Bile Duct / K.Uchiyama et al. / p420~420
  • General Lecture 570. Radio-hyperthermia for Pancreas Cancer / N.Hino et al. / p421~421
  • General Lecture 571. Intraoperatvie RF Capacitive Hyperthermia for Unresectable Pancreatic Cancer / I.Hashida et al. / p421~421
  • General Lecture 572. Blood Flow Evaluation Using the Thermal Clearance Curve / K.Sugimoto et al. / p421~421
  • General Lecture 573. Therapeutic Results of Local Hyperthermia for Patients with Peritoneal Metastases of Gastric Cancer (CHPP and RF Heating) / Y.Inoue et al. / p422~422
  • General Lecture 574. Clinical Evaluation of Intraperitoneal Hyperthermic Perfusion(IPHP)for Advanced Gastric Cancer / R.D.Shrestha et al. / p422~422
  • General Lecture 575. Continuous Hyperthermic Peritoneal Perfusion with Cisplatin and Mitomycin C for Peritoneal Dissemination in Gastric Cancers / T.Fujimura et al. / p422~422
  • General Lecture 576. Efficacy of Continuous Hyperthermic Peritoneal Perfusion(CHPP)with Whole Body Hypothermia on Survival Rate of Advanced Gastric Cancer / Y.Masuda et al. / p423~423
  • General Lecture 577. Not Received / /
  • General Lecture 578. Evaluation of the Efficacy of Hyperthermia Combined with Misonidazole from a Standpoint of Tumor Tissue Blood Flow(TbF) / K.Kobayashi et al. / p423~423
  • General Lecture 579.Hyperthermochemotherapy Using a Thermosensitizer and ACNU / M.Kokubun et al. / p423~423
  • General Lecture 580. Subsets of T Lymphocytes in Patients with Cancer in the Female Genital Organ Analysis Using Two Color Flow Cytometry / K.Miyazaki et al. / p424~424
  • General Lecture 581. Production of Interferon-y in Peripheral Blood Mononuclear Cells in Patients with Uterine Cervical Cancer / T.Hanabayashi et al. / p424~424
  • General Lecture 582. Production of Interferon-y and Effect of Its Production by Monocyte in Gynecological Cancer / S.Yamagiwa et al. / p424~424
  • General Lecture 583. Killer T Cell Activity Specific to Epstein-Barr Virus in Patients with Carcinoma of Female Genital Tract / Y.Kitano et al. / p425~425
  • General Lecture 584. Study of Lymphocyte Subset Infiltrated into the Endometrial Cancer Tissue / H.Noguchi et al. / p425~425
  • General Lecture 585. Anti-tumor Activity in Regional Lymph Nodes of the Patients with Genito-urinary Tract Cancer / M.Yamashita et al. / p425~425
  • General Lecture 586. Peripheral Lymphocyte Subsets in Therapy Resistance stage D Prostatic Cancer Patients / J.Suwata et al. / p426~426
  • General Lecture 587. Studies on Splenectomy for Gastric Cancer Patients in Terms of Cellular Immunity / H.Yamagishi et al. / p426~426
  • General Lecture 588. A Study for the Significance of Splenectomy in Surgery for Gastric Cancer I. The Effects of Splenectomy on Survival Rate and Immunological Parameters / T.Toge et al. / p426~426
  • General Lecture 589. Clinical Evaluation of Splenectomy in stage 4 Gastric Cancer Patients / K.Iwata et al. / p427~427
  • General Lecture 590. Not Received / /
  • General Lecture 591. Effect of Blood Transfusions on Prognosis of Stomach Cancer / A.Kawaguchi et al. / p427~427
  • General Lecture 592. Not Received / /
  • General Lecture 593. Enhancement of Tumor Growth by Blood Transfusions / N.Takeuchi et al. / p427~427
  • General Lecture 594. Hyperthermia for Malignant Glioma by Radiofrequency Capacitive Heating Using Different Sized Applicators / H.Hondo et al. / p428~428
  • General Lecture 595. Interstitial Hyperthermia of Brain Tumor by Implant Heating System / T.Kobayashi et al. / p428~428
  • General Lecture 596. Effect of Combined Treatment by Magnetic Induction Hyperthermia Using Ferromagnetic Implants and Chemotherapy(ACNU)
  • Experimental Study on Rabbit Brain Tumor Model / K.Hattori et al. / p428~428
  • General Lecture 597. Not Received / /
  • General Lecture 598. Not Received / /
  • General Lecture 599. Clinical Experience in Hyperthermia for Head and Neck Cancers / S.Umino et al. / p429~429
  • General Lecture 600. Clinical Result of Advanced Esophageal Carcinoma Treated with Hyperthermia / I.Yamashita et al. / p429~429
  • General Lecture 601. Two Cases of Malignant Tumor Treated with a Combination of Regional Hyperthermia and Chemotherapy / A.Kishi et al. / p429~429
  • General Lecture 602. Multidisciplinary Treatment with Combined Hyperthermia,Chemotherapy and Radiotherapy for Postoperative Management or Treatment of Recurrent Gastrointestinal Tract Malig-nancies / M.Endow et al. / p430~430
  • General Lecture 603. Hyperthermia Therapy Used Thermotron RF8 for Bone Mets or Bone Inverted Lesions of Malignant Tumors / N.Muta et al. / p430~430
  • General Lecture 604. Application of Human Tumor Clonogenic Assay in Thermochemotherapy / A.Murakami et al. / p430~430
  • General Lecture 605. Potentiation Mechanism of the Cytotoxic Effect of FT-207 by Hyperthermia / M.Miyake et al. / p431~431
  • General Lecture 606. Rapid Hyperthermic Sensitivity Test Using Contact-sensitive Plates of Confluent Balb/c 3T3 Cell Monolayers / H.Matsuoka et al. / p431~431
  • General Lecture 607. Evaluation of the Immunological Dynamics and Nutrition on Patients with Cancer of Digestive Organ / K.Sato et al. / p431~431
  • General Lecture 608. Analysis of Cellular Immunity of Peritoneal Exudate Cells(PECs)and Peripheral Blood Cells in Patients with Early Gastric Cancer / T.Miyama et al. / p432~432
  • General Lecture 609. Immunological Analyses of Gastric and Colorectal Cancer Patients with High LAK Activity / Y.Korosu et al. / p432~432
  • General Lecture 610. ATPase Activity in Granulocytes from Patients with Carcinomas of the Gastro-intestinal Tract(GI Carcinoma) / T.Taniguchi et al. / p432~432
  • General Lecture 611. Behavior of Peripheral granulocytes in Cancer Patients(The 2nd Report) / H.Ubukata et al. / p433~433
  • General Lecture 612. Evaluation of in vitro PGE₂ Production in Human Peripheral Mononuclear Cells(PMC)Derived from Healthy Subjects and Patients with Cancer / M.Terada et al. / p433~433
  • General Lecture 613. The Relationship between Soluble Factors by Peripheral Blood Mononuclear Cells and Glucocorticoids Levels of Cancer Patients / K.Ito et al. / p433~433
  • General Lecture 614. Analysis of Immunocompetent Cells of Cancer Patients Treated with Anticancer Drugs / Y.Mitachi et al. / p434~434
  • General Lecture 615. Evaluation of the Immunological Dynamics on Patients with Cancer of Digestive Organs / M.Kinjo et al. / p434~434
  • General Lecture 616. Spleen Lymphocyte Subsets of Patients with Gastric Cancer--Analysis by Two Color Flow Cytemetry / M.Takahashi et al. / p434~434
  • General Lecture 617. Studies on Subsets of Lymphocytes in Peripheral Blood and Splenic Venous Blood in Patients with Gastric Cancer by Using Two-color Flow Cytometry / A.Takagane et al. / p435~435
  • General Lecture 618. Changes in Lymphocyte Subsets with Postoperative Chemotherapy(UFT,CPM)for Breast Carcinoma--A Comparative Study Using Two Colour Analysis / M.Kimura et al. / p435~435
  • General Lecture 619. Usefulness of Su-PS Skin Reaction in Patients with Resected Lung Cancer / A.Ogasawara et al. / p435~435
  • General Lecture 620. Autologous Mixed Lymphocyte Reaction(AMLR)in the Peripheral Blood and Spleen of Gastric Cancer Patients / M.Iwahashi et al. / p436~436
  • General Lecture 621. The Importance of Examination into the Combined Effect of Hyperthermia and Chemother-apy by Using Contact-sensitive Plate(CSP) / K.Yano et al. / p436~436
  • General Lecture 622. Effects of Hyperthermia on DNA Synthesizing Enzymes in Bone Marrow Cells in Patients with Acute Leukemia / H.Kudo et al. / p436~436
  • General Lecture 623. The Experimental Study of Laserthermia for the Human Gastric Cancer Transplanted to the Nude Mice / H.Narumi et al. / p437~437
  • General Lecture 624. Enhancement of Antitumor Effect of Antitumor Drugs by Hyperthermia in vitro / Y.Sakaguchi et al. / p437~437
  • General Lecture 625. Enhancement of Antitumor Effect of Immunotherapy Combined with Hyperthermia / K.Mise et al. / p437~437
  • General Lecture 626. Experimental Study of Local Hyperthermic Chemotherapy with Angiotensin-II for Malignant Bone Tumor(Part II) / F.Kinoshita et al. / p438~438
  • General Lecture 627. Feasibility of Total-body Hyperthermia by Whole Abdominal Hyperthermia Using RF Capacitive Hyperthermia System / R.Harnazoe et al. / p438~438
  • General Lecture 628. Comparison of Combined Effects of CDDP,OK-432 and Mild Systemic Hyperthermia in Two Ascites Tumor-host Systems / K.Komatsu et al. / p438~438
  • General Lecture 629. Thermal Enhancement Effects of TMF and VDS / I.Tsukiyama et al. / p439~439
  • General Lecture 630. Change in Heart Rate of Mice under Systemic Hyperthermia and Its Modification / W.Nakamura et al. / p439~439
  • General Lecture 631. Results of Chemohyperthermia via Intraperitoneal Irrigation on Disseminated Peritoneal VX2 Carcinoma in Rabbits / H.Yasuda et al. / p439~439
  • General Lecture 632. Selective Hyperthermia to Deep-seated Tumors Using Ferromagnetic Particles as a Target on the Rabbit Hepatic VX2-carcinomas / M.Hase et al. / p440~440
  • General Lecture 633. Studies on High Frequency Inductive Heating by Liposomal Ferromagnetic Particles / S.Suzuki et al. / p440~440
  • General Lecture 634. Effect of Hyperthermia on Lipid Peroxidation(LPO)and Superoxide Dismutase(SOD)in Experimental Liver Tumor / K.Suzuki et al. / p440~440
  • General Lecture 635. A Phase II Trial with Cisplatin, Vindesine and Bleomycin for Esophageal Cancer / N.Mizunuma et al. / p441~441
  • General Lecture 636. Clinical Evaluation of Postoperative Aggressive Chemotherapy for Thoracic Esophageal Cancer Patients who Underwent Curative Resection of Primary Lesion / K.Hirayama et al. / p441~441
  • General Lecture 637. Clinical Evaluation of Combination Chemo-radiotherapy Including CDDP for Esophageal Cancer / K.Ikeda et al. / p441~441
  • General Lecture 638. Combination Therapy Using Irradiation, CDDP and VDS for Lymph Node Recurrence of Esophageal Cancer / K.Okuyama et al. / p442~442
  • General Lecture 639. Evaluation of Efficacy of CDDP for Hepatocellular Carcinoma / M.Tanei et al. / p442~442
  • General Lecture 640. Phase II Study of Cisplatin for Hepatocellular Carcinoma / Y.Shirnada et al. / p442~442
  • General Lecture 641. Clinical Trial of Intravenous Mitoxantrone in Patients with Advanced Hepatocellular Carcinoma / T.Yoshida et al. / p443~443
  • General Lecture 642. DNA Alkyltransferase Activity in Human Cancer Tissue and Selective Cure of Deficient Tumor with ACNU / G.Isowa et al. / p443~443
  • General Lecture 643. Effect of MQF-OK and MQF-OK-UFT Therapy for Advanced Gall Bladder Cancer and Bile Duct Cancer / Y.Tamura et al. / p443~443
  • General Lecture 644. Results of Chemotherapy for Unresectable Pancreatic Carcinoma / T.Isawa et al. / p444~444
  • General Lecture 645. Adjuvant Chemotherapy with Mitomycin C(MMC)and Tegafur (FT) after Surgical Resection of Colorectal Carcinoma A Preliminary Report / S.Kodaira et al. / p444~444
  • General Lecture 646. Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Carcinoma(Second Report)3-year Survival after Surgery / K.Kunitomo et al. / p444~444
  • General Lecture 647. A Multi-Institutional Study on Pre- and Postoperative Adjuvant Chemotherapy for Colorectal Cancer / K.Futami et al. / p445~445
  • General Lecture 648. Not Received / /
  • General Lecture 649. The Study on Pre and Post Operative Adjuvant Chemotherapy for Colorectal Cancer (Part 1) -The Concentration of the Drug in Tissues Following Administrated UFT / T.Shimoyama et al. / p445~445
  • General Lecture 650. Clinical Evaluation of Postoperative Adjuvant Chemotherapy for Rectal Carcinoma / H.Ishikawa et al. / p445~445
  • General Lecture 651. A Randomized Controlled Trial Comparing Short-term MF Chemotherapy with MF plus Long-term HCFU Chemotherapy as an Adjuvant to Curative Resection of Stomach Cancer / H.Nakazato et al. / p446~446
  • General Lecture 652. Prospective Adjuvant Therapy of Carmofur(HCFU)plus OK-432 for stage III,IV Stomach Cancer(The First Report)Mifurol Study Group for Stomach Cancer-Second Study / K.Kato et al. / p446~446
  • General Lecture 653. Adjuvant Chemotherapy with HCFU for Resectable Colorectal Carcinoma / T.Muto et al. / p446~446
  • General Lecture 654. Prospective Adjuvant Chemotherapy of Mitomycin C plus HCFU for Colorectal Cancer (The Third Report) -7 Year Survival after Surgery / H.Ichihashi et al. / p447~447
  • General Lecture 655. A Randomized Controlled Study on Adjuvant Chemotherapy with Mitomycin C and HCFU in Noncuratively Resected-Colorectal Cancer Patients(Fourth Report) / M.Niimoto et al. / p447~447
  • General Lecture 656. Prospective Adjuvant Therapy of Carmofur(HCFU)plus PSK for Colorectal Cancer / T.Watanabe et al. / p447~447
  • General Lecture 657. A Case of Hepatocellular Carcinoma(HCC) with Lung Metastasis which Responded to Chemotherapy with a Single Use of HCFU / Y.Kanda et al. / p448~448
  • General Lecture 658. Combination Chemotherapy with Etoposide(E),Adriamycin(A),and Cisplatin(P)(EAP)for Advanced Gastric Cancer / A.Tanaka et al. / p448~448
  • General Lecture 659. Effect of Concomitant Therapy of Cisplatin,MMC,UFT and Etoposide(PMU-E Therapy)on Terminal Stomach Cancer / T.Sawa et al. / p448~448
  • General Lecture 660. Chemotherapy for Advanced and Recurrent Cancer Patients--Effects of Combination Chemotherapy Using Cisplatin,Peplomycin,Mitomycin C and Adriamycin / Y.Sato et al. / p449~449
  • General Lecture 661. Phase II Study of Cisplatin for Gastric Carcinoma and Colon Carcinoma / K.Ishibiki et al. / p449~449
  • General Lecture 662. Prognostic Factors in Unresectable Advanced Gastric Cancer Cases Treated by Chemotherapy / A.Ohtsu et al. / p449~449
  • General Lecture 663. Experience of CDDP Therapy for Advanced or Recurrent Gastric Cancer--With Special References to the Relationship between Response Rate and Nuclear DNA Histogram / T.Chikaishi et al. / p450~450
  • General Lecture 664. Preoperative Chemotherapy and Anti-cancer Effect of Stomach Carcinoma / K.Kumagai et al. / p450~450
  • General Lecture 665. Prognosis of the Patients with Resectable Advanced Gastric Cancer, Treated by Preoperative Chemotherapy / S.Yoshida et al. / p450~450
  • General Lecture 666. Preoperative Chemotherapy in Gastric and Colorectal Cancer / Y.Munemoto et al. / p451~451
  • General Lecture 667. Preoperative Chemotherapy for Soft Tissue Sarcomas / Y.Aoki et al. / p451~451
  • General Lecture 668. Advanced and Recurrent Gastric/Rectal Carcinoma Responding to Etoposide,Adriamycin and Cisplatin(EAP)Therapy / Y.Nakamura et al. / p451~451
  • General Lecture 669. Clinical Evaluation of Combination Chemotherapy with Etoposide(Etop)/Adriamycin(ADM)/Cisplatin(CDDP)--EAP-in Advanced Gastrointestinal Cancer / T.Ohno et al. / p452~452
  • General Lecture 670. Advanced and Recurrent Carcinoma of Digestive Organs:Combination Chemotherapy with Etoposide(E),Adriamycin(A), Cisplatin(P)=EAP / S.Owada et al. / p452~452
  • General Lecture 671. Clinical Studies on Cisplatin-based Combination Cancerchemotherapy / N.Terata et al. / p452~452
  • General Lecture 672. A Comparative Study of MMC+UFT and MMC+Tegafur Therapies for Advanced Cancer of Gastrointestinal Tract / Y.Inoue et al. / p453~453
  • General Lecture 673. A Combination Chemotherapy with Adriamycin,Mitomycin C and Tegafur or 5-FU(AMF) for Advanced or Recurrent Cancer of Digestive Organ or Breast / Y.Rai et al. / p453~453
  • General Lecture 674. Evaluation of Activity in Patients with Advanced Cancer during the Course of Chemotherapy with UFT,MMC,and Picibanil / S.Misawa et al. / p453~453
  • General Lecture 675. The Combination Chemotherapy of MTX-5FU for Recurrent and Advanced Cancer Patients / T.Saeki et al. / p454~454
  • General Lecture 676. Intravenous Infusion of 5-fluorouracil(1)Once-a-week Intermittent Administration / T.Nakatsu et al. / p454~454
  • General Lecture 677. Trial Chemoendocrine Therapy(MAPET)for Stage D₂Prostatic Cancer / H.Kusuyama et al. / p454~454
  • General Lecture 678. Combination Chemotherapy for Stage D₂, Advanced Prostatic Cancer with Ifosfamide,5-Fluorouracil,and Cisplatin / S.Takeuchi et al. / p455~455
  • General Lecture 679. Phase II Study of Vindesine for Urogenital Cancer / J.Ochi et al. / p455~455
  • General Lecture 680. Clinical Evaluation of PVB Chemotherapy for Testicular Cancer / N.Miyanaga et al. / p455~455
  • General Lecture 681. Experience with a New Second Line Combination Chemotherapy for Testicular Tumors / H.Iizawa et al. / p456~456
  • General Lecture 682. Clinical Research on Testicular Tumors--The Effectiveness of Chemotherapy in Relation to Resection of Metastatic Tumors / A.Furuhata et al. / p456~456
  • General Lecture 683. CAF Chemotherapy on Advanced and Recurrent Breast Cancer(2nd Report) / C.Masuzawa et al. / p456~456
  • General Lecture 684. Combined Chemotherapy with CDDP,VDS and VP-16 for CAF Therapy Resistant Relapsed Breast Cancer / O.Senga et al. / p457~457
  • General Lecture 685. Postoperative Adjuvant Therapy for Breast Cancer / T.Morimoto et al. / p457~457
  • General Lecture 686. Combination Chemotherapy Consisting of Mitomycin C,Methotrexate,5-FU(MMF)as Second Line for Refractory, Advanced Breast Cancer / T.Fujii et al. / p457~457
  • General Lecture 687. Anti-tumor Effect of Trilostane(MWD-18)for Breast Cancer / K.Hayashi et al. / p458~458
  • General Lecture 688. Not Received / /
  • General Lecture 689. Combination Therapy with 5'-DFUR in the Treatment of Breast Cancer and Gastrointestinal Cancer / T.Taguchi et al. / p458~458
  • General Lecture 690. Adjuvant Systemic Therapy for Resectable Breast Cancer]--Does Response Prolonged Survival? / H.Yamamoto et al. / p458~458
  • General Lecture 691. Phase II Study of Combination Chemotherapy with Epirubicin(Epi),Cyclophosphamide(CPM)and Ftrafur(FT)for Metastatic Breast Cancer / M.Tabata et al. / p459~459
  • General Lecture 692 Combination Chemo-endocrine Therapy of Metastatic Breast Cancer with Cyclophosphamide,Adriamycin,Prednisolone and Tamoxifen(CAPT) / Y.Nakamura et al. / p459~459
  • General Lecture 693. Five-day Continuous Infusion of Vindesine and Vinblastine in the Treatment of Advanced Malignancies / N.Usui et al. / p459~459
  • General Lecture 694. Evaluation of Quality of Life of Postmastectomy Patients by Questionnaire / T.Kiyoizumi et al. / p460~460
  • General Lecture 695. Evaluation of the Quality of Life in Patients after Surgery for Gastric Cancer / S.Inaba et al. / p460~460
  • General Lecture 696. Home Oxygen Therapy for the Lung Cancer Patient with Respiratory Insufficiency / Y.Noguchi et al. / p460~460
  • General Lecture 697. The Investigation of Cure and Care in the Advanced Gastric Cancer / T.Fukuda et al. / p461~461
  • General Lecture 698. The Role of Radiotherapy in the Hospice Care / T. Nishimura et al. / p461~461
  • General Lecture 699. Clinical Evaluation of Morphine Sulfate Continous Tablet for the Patient of Gynecological Malignancy / S.Yokoyama et al. / p461~461
  • General Lecture 700. The Study on the Effect of the Administration of Betamethasone to the Patient with Advanced Cancer at Terminal stage / M.Miyashita et al. / p462~462
  • General Lecture 701. Opinion Research on Notification of Cancer and Terminal Care / K.Tsukada et al. / p462~462
  • General Lecture 702. Lymphadenectomy for the Renal Pelvic and Ureteral Tumors / T.Okano et al. / p462~462
  • General Lecture 703. Results of Treatment for Carcinoma of the Renal Pelvis and Ureter / M.Maruoka et al. / p463~463
  • General Lecture 704. Clinical Assessment for Superficial Bladder Tumors Treated by Transurethral Resection(TUR) / H.Tsujihashi et al. / p463~463
  • General Lecture 705. Treatment for T2 Transitional Cell Carcinoma of the Urinary Bladder / M.Kuroda et al. / p463~463
  • General Lecture 706. Clinical Studies on Total Cystectomized Bladder Cancer at Nagasaki Central Hospital from 1982 to 1987 / M.Hayashi et al. / p464~464
  • General Lecture 707. Surgical Treatment for Precancerous Lesions of the Colorectum / Y.Yamamoto et al. / p464~464
  • General Lecture 708. Surgery for Small Rectal Carcinoid Tumors--Mainly 1 cm or Smaller Lesions / H.Tomoda et al. / p464~464
  • General Lecture 709. Significance of Lateral Lymph Node Dissection in Rectal Cancer / M.Mori et at. / p465~465
  • General Lecture 710. Anastomotic Recurrence after Sphincter-saving Resection for Rectal Cancer--A Possible Role of Free Malignant Cells in the Lumen / I.Fukuda et al. / p465~465
  • General Lecture 711. Not Received / /
  • General Lecture 712. Abdominal Surgery among Those over 90 Years of Age / T.Kunizaki et al. / p465~465
  • General Lecture 713. Twenty-one Year Results of Treatment of Primary Operable Breast Cancer / T.Horino et al. / p466~466
  • General Lecture 714. Significance of-Parastemal Dissection as Radical Mastectomy / M.Ogita et al. / p466~466
  • General Lecture 715. Not Received / /
  • General Lecture 716. Results of Full Thickness Chest Wall Resection in Patients with Chest Wall Recurrence of Breast Cancer / K.Miyauchi et al. / p466~466
  • General Lecture 717. Clinical Evaluation of Modified Radical Mastectomy as Related to Locoregional Recurrence / G.Matsumiya et al. / p467~467
  • General Lecture 718. Tumor Necrosis Effect by Endogenous Tumor Necrosis Factor(TNF)Induction Therapy / H.Shinohara et al. / p467~467
  • General Lecture 719. Endogenous and Exogenous TNF Therapy on Metastatic or Local Recurrent Lesions of Colorectal Carcinoma / K.Takagi et al. / p467~467
  • General Lecture 720. An Analysis of the Clinical Effect and the Cellular Immune Response with Endogenous TNF Induction Therapy for Colon Cancer with Liver Metastasis / M. Kusama et al. / p468~468
  • General Lecture 721. Evaluation of the Effect of Natural Human TNF on Immune System / Y.Yasui et al. / p468~468
  • General Lecture 722. Anti-tumor Effect of Human Recombinant Tumor Necrosis Factor(Hu-rTNF)and Clinical Evaluation / T.Otuki et al. / p468~468
  • General Lecture 723. Endogenous Induction of Tumor Necrosis Factor Serum(TNS)for the Immunological Treatment of Cancer after Operation / Y.Abe et al. / p469~469
  • General Lecture 724. Not Received / /
  • General Lecture 725. Treatment of Recurrent Glioblastoma with PT-050,a Case Report / K. Kurisu et al. / p469~469
  • General Lecture 726. TNF Activity in the Sera of Patients with Head and Neck Carcinoma / H.Suzuki et al. / p469~469
  • General Lecture 727. Induction of Endogenous TNF Models by Streptococcal Preparation,OK-432 / M.Miyai et al. / p470~470
  • General Lecture 728. Antitumor Therapy of Gynecological Malignancies in Advanced stages through Induction of Endogenous TNF / K.Dobashi et al. / p470~470
  • General Lecture 729. A Case of Myosarcoma Uteri Treated with Endogenous Tumor Necrosis Factor(TNF) Induction Therapy / K,Taguchi et al. / p470~470
  • General Lecture 730. Maintenance Immunochemotherapy for Hormonally-refractory Prostatic Cancer / T.Yamauchi et al. / p471~471
  • General Lecture 731. A Histopathological Evaluation about Metastatic Lesions after EET Therapy / M.Kato et al. / p471~471
  • General Lecture 732. Analysis of Conditions for LAK Cell Induction Using Synthetic Medium / T.Tsuchida et al. / p471~471
  • General Lecture 733. Basic Investigation for Lymphokine Activated Killer Cell Induction / A.Murata et al. / p472~472
  • General Lecture 734. Induction of LAK Cells by Long Term Culture / S.Takamoto et al. / p472~472
  • General Lecture 735. Synergistic Effect of IL-2 and IFN-γ / T.Tsunoda et al. / p472~472
  • General Lecture 736. Not Received / /
  • General Lecture 737. The Effects of Neoplastic Drugs on Lymphokine Activate Killer(LAK)Activity and Natural Killer(NK)Activity / K.Yoshimori et al. / p473~473
  • General Lecture 738. Examination of Lymphokine-Activated Killer(LAK)Activity in Patients with Esophageal Cancer / K.Shimoda et al. / p473~473
  • General Lecture 739. Not Received / /
  • General Lecture 740. A Case of Advanced Renal Cell Carcinoma Responded to the Combined Immunotherapy / A.Usui et al. / p473~473
  • General Lecture 741. Clinical Trial of Tumor Ifiltrating Lymphocytes in Gynecological Cancer / G.Yahata et al. / p474~474
  • General Lecture 742. Brain Metastases after Immunotherapy with Autologous Lymphokine-activated Killer Cells and Interleukin 2 in Patients with Metastatic Renal Cell Carcinoma / E.Nakano et al. / p474~474
  • General Lecture 743. Induction of Autologous-tumor Specific Cytotoxic T Lymphocytes Restimulated in vitro with 1-butanol Extracted Tumor Antigen / K.Naito et al. / p474~474
  • General Lecture 744. Adoptive Chemoimmunotherapy with Cyclophosphamide(CY),IL-2 and Lymphokine Acti-vated Killer(LAK)Cells / M.Takahashi et al. / p475~475
  • General Lecture 745. LAK Cell Adoptive Immunotherapy in Combination with Plasma Exchange / T.Takayama et al. / p475~475
  • General Lecture 746. Not Received / /
  • General Lecture 747. Adoptive Immunotherapy of Malignant Diseases with Allogeneic LAK Cells / Y.Kimoto et al. / p475~475
  • General Lecture 748. Long-term Effect of Intravesical Instillation of BCG to Prevent Recurrence in Patients with Bladder Tumor / S.Jitsukawa et al. / p476~476
  • General Lecture 749. Prophylactic Effects of Intravesical Bacillus Calmette-Guerin on Superficial Bladder Tumor / K.Yoshikawa et al. / p476~476
  • General Lecture 750. A Comparative Clinical Trial of Intravesical ECG and UFT Treatment in Superficial Bladder Cancer / H.Oda et al. / p476~476
  • General Lecture 751. Subpopulations of Tissue Infiltrating Lymphocytes in Bladder Tumors Treated BCG Intravesical Instillution / T.Kawaguchi et al. / p477~477
  • General Lecture 752. Preventive Effect of Human Urinary Trypsin Inhibitor on Postgastrectomy Immunosuppression in Gastric Cancer Patient / K.Ogoshi et al. / p477~477
  • General Lecture 753. A Statistical Analysis on Cancer Patients in Treatment with S.S.M. (An Extract from Human Tubercle Bacilli
  • Maruyama Vaccine) -Report X / K.Fujita et al. / p477~477
  • General Lecture 754. Clinical Experiences of Plasma Perfusion over Immobilized Protein A(Pro-TAK)in Cancer Patients / T.Okada et al. / p478~478
  • General Lecture 755. Studies on Removal Effect of Immunosuppressive Factor by Protein A Column With Special References to the Augmentation on Cell Mediated Immunity of PBL and LAK Cells / T.Ooiwa et al. / p478~478
  • General Lecture 756. Clinical Studies on Plasma Perfusion over Immobilized Protein A in the Treatment of Cancer / S.Hata et al. / p478~478
  • General Lecture 757. Case Reports on Terminal Cancer of Urogenital Organs with Remarkable Efficacy Attained by Immuno-surveillance Therapy / I.Sato et al. / p479~479
  • General Lecture 758. Effects on Malignant Tumors of Treatment Combinding Radiotherapy with TCA Therapy / Y.Suzuki et al. / p479~479
  • General Lecture 759. Toxicity of M-VAC Therapy in Rats / H.Matsuki et al. / p479~479
  • General Lecture 760. Histopathological Study Regarding the Protective Effect of Elastase on Cisplatin-induced Renal Toxicity / M.Ohwada et al. / p480~480
  • General Lecture 761. Effect of Cisplatin on Mouse Spermatozoa / S.Oshio et al. / p480~480
  • General Lecture 762. Comparative Evaluation of Murine Oocyte Toxicity Following Intraovarian Injection and Intraperitoneal Infusion with Oncostatics / I.Yokoo et al. / p480~480
  • General Lecture 763. Effective Dose of 50% Destruction for Murine Oocyte Following Intraperitoneal Infusion of 12 Oncostatics / K.Takizawa et al. / p481~481
  • General Lecture 764. Characterization of Cisplatin Resistant Human Lung Cancer Cell Lines / Y.Fujiwara et al. / p481~481
  • General Lecture 765. Mechanisms of Resistance to Cisplatin in Ovarian Carcinoma Cells / T.Oosaki et al. / p481~481
  • General Lecture 766. Establishment of the Drug resistant Ovarian Cancer Cell Lines and Their Characterization / K.Mizuno et al. / p482~482
  • General Lecture 767. The Effect of Diprydamole on Cytotoxicity of Cisplatin Analogs in Parent and Cisplatin Resistant Ovarian Cell Lines / M. Hatae et al. / p482~482
  • General Lecture 768. Not Received / /
  • General Lecture 769. The Effect of Verapamil,Cyclosporin A or Buthionine-S,R-sulfoximine to Overcome the Drug Resistance against Primary Culture Cells / K.Minato et al. / p482~482
  • General Lecture 770. Not Received / /
  • General Lecture 771. A Case of Advanced Uterine Corpus Carcinoma Successfully Treated by Intra-arterial Chemotherapy Followed by Radical Operation / Y.Satow et al. / p483~483
  • General Lecture 772. Repertitive Intra-arterial Chemotherapy for Recurrence of Carcinoma of the Uterine Cervix / H Tanaka et al. / p483~483
  • General Lecture 773. A Trial for Individualization of Intra-arterial Infusion Chemotherapy / K.Fujiwara et al. / p483~483
  • General Lecture 774. Consecutive Intraarterial Infusion in Patients with Cervical Cancer Recurrent in the Pelvis after Radiation / S.Shiokawa et al. / p484~484
  • General Lecture 775. Clinical and Pathological Study in Preoperative CDDP Intra-arterial Chemotherapy for Cervical Cancer / T.Kondoh et al. / p484~484
  • General Lecture 776. Long Term Management of the Intra-arterial Catheter in the Internal Iliac Arteries / K.Kawagoe et al. / p484~484
  • General Lecture 777. Pharmacokinetics of CDDP Administered as a Short-term Intra-arterial Infusion(Second Report) / T.Kurose et al. / p485~485
  • General Lecture 778. Mesenterio-intra-arterial Infusion Chemotherapy for Peritonitis Carcinomatosa in Ovarian Cancer Patients / S.Adachi et al. / p485~485
  • General Lecture 779. Intra-arterial Chemotherapy of Advanced Gynecological Carcinoma Using Totally Implantable Delivery System / H.Inoue et al. / p485~485
  • General Lecture 780. Transcatheter Arterial Embolization in Cases of Recurrent and Advanced Cervical Cancer / Y.Harima et al. / p486~486
  • General Lecture 781. Application of Lymphadenectomy and Intraoperative Radiation Therapy of the Paraaortic Lymph Nodes in Advanced Cervical Cancer / T.Miyamoto et al. / p486~486
  • General Lecture 782. Intraoperative Radiotherapy for Recurrent Uterine Cancer / J.Oomagari et al. / p486~486
  • General Lecture 784. Experience of Step Wedges Used to Shield the Midline during External Irradiation for Carcinoma of Uterine Cervix / H.Sekine et al. / p487~487
  • General Lecture 785. Preoperative Irradiation Therapy for Vulva Carcinoma / H.Gomi et al. / p487~487
  • General Lecture 786. Intravesical or Intrarectal Instillation of Maalox for the Treatment of Radiation Cystitis or Proctitis / Y.Koizumi et al. / p487~487
  • General Lecture 787. High-Dose Rate Intracavitary Therapy for Carcinoma of the Uterine Cervix:Prospective Randomized Study of Point A Dose of 7.5 Gy vs 6 Gy/Fraction / T.Teshima et al. / p488~488
  • General Lecture 788. High Dose Rate Intracavitary Radiotherapy of Recurrent Cervical Cancer / H.Kumagai et al. / p488~488
  • General Lecture 789. The Prognosis of Cervical Cancer Patients in Reference to Its Radio-sensitivity / T.Hamada et al. / p488~488
  • General Lecture 790. Experimental Studies on Irradiation Effect with Anticancer Drugs / K.Morishita et al. / p489~489
  • General Lecture 791. Relationship between Prognosis and Lymph Node Metastases with Postoperative Radiother-apy of Carcinoma of the Uterine Cervix / M.Kumano et al. / p489~489
  • General Lecture 792. Correlation between the Prognosis and Cytology and Histology during Irradiation for Cervical Cancer / M.Takahashi et al. / p489~489
  • General Lecture 793. Remote Afterloading Transurethral Radiotherapy for Prostatic Cancer / T.Kigure et al. / p490~490
  • General Lecture 794. Study on Conformation Radiotherapy for Prostatic Carcinoma / T.Takahashi et al. / p490~490
  • General Lecture 795. Clinical Evaluation of Intracavitary Radiotherapy for Bladder Cancer / T.Inoue et al. / p490~490
  • General Lecture 796. Combined Cisplatin and Radiation Therapy for Advanced Bladder Cancer / M.Matsushima et al. / p491~491
  • General Lecture 797. Conbination Effects of Proton and CDDP on the Invasive Bladder Carcinoma in Mice / M.Ohtani et al. / p491~491
  • General Lecture 798. Radiation Therapy for Nasopharyngeal Carcinoma / H.Uozumi et al. / p491~491
  • General Lecture 799. Radiotherapy of Oropharyngeal Squamous Cell Carcinoma / M.Uematsu et al. / p492~492
  • General Lecture 800. Results of Radiotherapy for T1N0M0 Glottic Carcinoma / T.Inoue et al. / p492~492
  • General Lecture 801. Results of Radiotherapy for T1.2 Supraglottic Carcinoma / Y.Matayoshi et al. / p492~492
  • General Lecture 802. Long-term Results in T1 Glottic Carcinoma / M.Saikawa et al. / p493~493
  • General Lecture 803. Preoperative Radiotherapy for Invasive Thymoma / K.Ohara et al. / p493~493
  • General Lecture 804. Prognostic Factor of Patients with stage I,II ca.of the Tongue Treated by Interstitial Radiotherapy / K.Jingu et al. / p493~493
  • General Lecture 805. Malignant Tumors Metastatic to the Mouth / T.Shimizu et al. / p494~494
  • General Lecture 806. Results of Radiotherapy for Maxillary Sinus Cancer / K.Matsuki et al. / p494~494
  • General Lecture 807. Treatment of MO-advanced Head and Neck Cancer by Combined Radiotherapy with Misonidazole and Vidarabine / H.Asakura et al. / p494~494
  • General Lecture 808. Radiosensitivity Test for Carcinomas through Immunohistochemical Method / A.Nishioka et al. / p495~495
  • General Lecture 809. Modified Arc Therapy for TSEI,TBI and Large Field Irradiations--A Susequent Report / M.Daimon et al. / p495~495
  • General Lecture 810. Contrast Enhancement and Treatment Policies in Grade II Gliomas / A.Akanuma et al. / p495~495
  • General Lecture 811. Intraoperative Radiation Therapy(IORT)for Cerebral Glioblastoma / M.Matsutani et al. / p496~496
  • General Lecture 812. Radiotherapy of Central Neurocytoma / K.Nakagawa et al. / p496~496
  • General Lecture 813. Not Received / /
  • General Lecture 814. Proton Therapy for Ocular Malignancy / S.Morita et al. / p496~496
  • General Lecture 815. A Preliminary Report of Endocrine Chemotherapy in Endometrial Cancer / Y.Katsube et al. / p497~497
  • General Lecture 816. Inhibition of Metastasis in Gynecologic Malignant Tumors by Medroxyprogesterone Acetate with Reference to Tumor Angiogenesis Factor and Fibroblast Growth Factor / S.Hosoda et al. / p497~497
  • General Lecture 817. Steroid Hormone Producing Activity of Ovarian Endometrioid Adenocarcinoma / Y.Ino et al. / p497~497
  • General Lecture 818. Clinical Evaluation of Medroxyprogesterone Acetate and 5-Fluorouracil for Maintenance Therapy of Prostatic Carcinoma / K. Kojima et al. / p498~498
  • General Lecture 819. Treatment of stage D₂ Prostate Cancer Patients with Hormones in Combination with Cyclophosphamide / I.Nakamura et al. / p498~498
  • General Lecture 820. Therapeutic Effects on Carcinoma Cells in Prostatic Fluid / S.Ichijo et al. / p498~498
  • General Lecture 821. A Combination Therapy with MPA and 5'DFUR as a Second Line Treatment for Advanced/Recurrent Breast Cancer(Second Report) / H. Koyama et al. / p499~499
  • General Lecture 822. Not Received / /
  • General Lecture 823. Time-course of Estrogen and Progesterone Receptor Contents during Tamoxifen-medroxyprogesterone Sequential Therapy for Breast Cancer / S.Noguchi et al. / p499~499
  • General Lecture 824. A Comparison of Two Doses of Tamoxifen in the Patients with Advanced Breast Cancer:40 mg/day v.s. 20 mg/day / Y.Takatsuka et al. / p499~499
  • General Lecture 825. Clinical Trial of Combination Therapy with Medroxyprogesterone Acetate plus Tegafur for Adriamycin and Tamoxifen Resistant Advanced Breast Cancers / T.Wada et al. / p500~500
  • General Lecture 826. Adjuvant Chemo-endocrine Therapy with Tegafur and Tamoxifen for Breast Cancer(1st.Report) / H.Koyama et al. / p500~500
  • General Lecture 827. The Effects of the Combined Use of Testosterone and Tamoxifen on DMBA-induced Mammary Tumor in Rats / N.Okuyama et al. / p500~500
  • General Lecture 828. Dose-related Side Effects and Plasma Concentration of MPA / M.Fukuda et al. / p501~501
  • General Lecture 829. Changes of Estrogen Receptor Expression by Endocrine Therapy in Breast Cancer / M.Toi et al. / p501~501
  • General Lecture 830. Prognostic Value of Estrogen and Progesterone Receptor Determinations in Patients with Primary Operable Breast Cancer / J.Kurebayashi et al. / p501~501
  • General Lecture 831. Comparison of Modified Charcoal-gelatin(MCG)Method with Standard DCC for Estrogen Receptor Assay / S.Masamura et al. / p502~502
  • General Lecture 832. Study of the Hormone Dependency of Human Breast Cancer by Using Serum-free Culture / K.Urazumi et al. / p502~502
  • General Lecture 833. A Study on Aromatase and Sulfatase Activities in Breast Cancer Tissue / T.Utsumi et al. / p502~502
  • General Lecture 834. Antitumor Effects and Endcrine Status of New Aromatase Inhibitor(CGS 19649 A)on DMBA-Induced Rat Mammary Cancer / T.Hohjoh et al. / p503~503
  • General Lecture 835. Estrogen Receptor in Gastric Cancer and Early Results of Endocrine Treatment for Gastric Cancer / A.Tokunaga et al. / p503~503
  • General Lecture 836. Effect of Tamoxifen to Human Gastric Cancer Cell Lines:A Flow Cytometry Analysis / H.Ohkura et al. / p503~503
  • General Lecture 837. Estrogen Receptor Related Antigen(ER-D5)in Gastric Cancer / H.Matsumoto et al. / p504~504
  • General Lecture 838. Immunohistochemical Study of Estradiol,Cholesterol Side-chain Cleavage Enzyme,Aromatase,Estrogen Receptor in Gastric Cancer / Y.Saitou et al. / p504~504
  • General Lecture 839. Prognosis of Breast Cancer Patients and ER Stainability / M.Matsui et al. / p504~504
  • General Lecture 840. Not Received / /
  • General Lecture 841. On the Correlation of Immunocytochemically Demonstrated Estrogen Receptor Status(ER-ICA)and Histopathological Features in Breast Cancer / H.Matsukawa et al. / p505~505
  • General Lecture 842. Studies on Susceptibility to Chemotherapeutic Agents and Targeting Chemotherapy Using Multicellular Tumor Spheroid(MTS) / S.Inoue et al. / p505~505
  • General Lecture 843. Targeting Chemotherapy by Transferrin-neocarzinostatin Conjugate:Relationship between the Molar Ratio of NCS and the Antitumor Effect / J.Kato et al. / p505~505
  • General Lecture 844. An Experimental Study on Antitumor Effect of Prostaglandin D₂ / H. Ehara et al. / p506~506
  • General Lecture 845. Effects of δ 12-prostaglandin J₂ on Tumor Proliferation / G.Nishimura et al. / p506~506
  • General Lecture 846. Indomethacin Enhances the Cytostatic Effect of CDDP on the Cell Growth of the Uterine Cervical Cancer in Cell Line / M.Ogino et al. / p506~506
  • General Lecture 847. Inhibitory Effect of Antitumor Drugs-induced Sister Chromatid Exchanges by Im-munopotentiator PS-K / J.Hasegawa et al. / p507~507
  • General Lecture 848. Dipyridamole Enhances Cytotoxic Effect of Adriamycin on the Tumor Cells / K.Hidaka et al. / p507~507
  • General Lecture 849. Effects of α-Difluoromethylornithine,Methylglxal-bis-guanylhydozone and Recombinant Interferon-γ on the Growth of Human Breast Cancer(R-27)in Nude Mice / T.Koga et al. / p507~507
  • General Lecture 850. Experimental Lung Cancer Chemotherapy Using Transplantable Human Lung Cancer in Nude Mice / M.Imaizumi et al. / p508~508
  • General Lecture 851. Antitumor Effect of 5FU by Administration Schedule on Human Gastric Cancer Transplanted in Nude Mice / D.Saito et al. / p508~508
  • General Lecture 852. Antitumor Activity of Mitomycin C Analogous Compounds(KT 6149 and RM-49)against Human Tumor Xenografts Serially Transplanted into Nude Mice / T.Kubota et al. / p508~508
  • General Lecture 853. Not Received / /
  • General Lecture 854. Transport and Intracellular Metabolism of Fluoropyrimidines in Intraperitoneally Cultured and in-vitro Cultured HeLa-S₃Cells / M.Uchida et al. / p509~509
  • General Lecture 855. Preoperative Intra-arterial Infusion Chemotherapy for Patients with T2/T3 Bladder Cancer / Y.Kubota et al. / p509~509
  • General Lecture 856. Multidisciplinary Treatment Including Intraarterial Infusion Chemotherapy for Advanced Bladder Cancer / T.Tochigi et al. / p509~509
  • General Lecture 857. Radiation and Intra-arterial Chemotherapy with Angiotensin II to Bladder Cancer / T.Nasu et al. / p510~510
  • General Lecture 858. Efficacy of Intraarterial Chemotherapy Using CDDP on Rat Bladder Tumors Induced by BBN / Y.Furukawa et al. / p510~510
  • General Lecture 859. Immunological Effects of Recombinant Interferon-γ Infused by Renal Artery for Renal Malignancies / S.Isaka et al. / p510~510
  • General Lecture 860. Tumor-targeted Chemotherapy with Lipid Contrast Medium and Macromolecular Anti-cancer Drug(SMANCS)for Renal Cell Carcinomas Renal Arterial Administration of SMANCS/Lipiodol Hyper Viscosity / M.Kobayashi et al. / p511~511
  • General Lecture 861. Transcatheter Arterial Oily Chemoembolization of Renal Carcinoma with Adriamycin-Lipiodol-emulsion / T.Nishiyama et al. / p511~511
  • General Lecture 862. Countrermeasures to Cope with Problems Relating to Continuous Intraarterial Infusion Therapy / Y.Nomura et al. / p511~511
  • General Lecture 863. A Study of Long Term Results of Intra-arterial Chemotherapy of Breast Cancer, Especially in Local Control / S.Takehara et al. / p512~512
  • General Lecture 864. Intra-arterial Infusion Chemotherapy on Primary Advanced Breast Cancer--Effect and Side Effect of ADR and. 4'-epi-ADR / K.Toda et al. / p512~512
  • General Lecture 865. Intra-Arterial Chemotherapy with CDDP for Primary Mediastinal Seminoma / H. Kuritsuka et al. / p512~512
  • General Lecture 866. Preoperative Chemotherapy of Osteosarcoma with Intra-arterial Cisplatin / A. Suda / p513~513
  • General Lecture 867. The Use of IAP in the Judgement of Therapeutic Effects in the Treatment of Patients with Ranal Cell Carcinoma / M.Hoshino et al. / p513~513
  • General Lecture 868. Significance of Serum IAP,TPA and Ferritin Levels in Renal Cell Carcinoma / T. Igarashi et al. / p513~513
  • General Lecture 869. Clinical Evaluation of Basic Fetoprotein(BFP)in Human Renal Cell Carcinoma / K. Gohji et al. / p514~514
  • General Lecture 870. Clinical Evaluation of Serum BFP Levels in Urogenital Tumors and Urinary BFP Levels in Bladder Cancer / Y.Nagatani et al. / p514~514
  • General Lecture 871. Usefulness of Urinary BFP(Basic Fetoprotein)as a Marker for Detecting Urothelial Malignancies / T.Tsujii et al. / p514~514
  • General Lecture 872. Clinical Studies on the Measurement of Urinary TPA Levels in Urothelial Cancer / T.Ohashi et al. / p515~515
  • General Lecture 873. Screening Examination for Bladder Cancer
  • Measurement of Antigens in Urine by Using Monoclonal Antibodies / Y.Aga et al. / p515~515
  • General Lecture 874. Clinical Significance of PAP in stage D₂ Prostatic Carcinoma / Y.Satoh et al. / p515~515
  • General Lecture 875. Role of γ-Seminoprotein(γ-Sm)and Prostatic Acid Phosphatase(PAP)as the Tumor Markers of Prostatic Cancer / M.Watanabe et al. / p516~516
  • General Lecture 876. Clinical Evaluation of Serum Prostatic Specific Antigen, γ-seminoprotein and Prostatic Acid Phosphatase in Prostatic Cancer / Y. Arai et al. / p516~516
  • General Lecture 877. The Usefulness of PAP, γ-Sm and PA as the Evaluation of Clinical Effects in the Treatment of Prostatic Cancer / K.Ohta et al. / p516~516
  • General Lecture 878. Comparative Evaluation Study of PAP, PA and γ-Sm as Tumor Markers for Prostatic Cancer Patients / H. Ito et al. / p517~517
  • General Lecture 879. Indication of Adjuvant Hepatic Arterial Chemotherapy after Hepatectomy for Hepatoma According to Analysis of Risk Jaetors of Recurrence / T. Nonami et al. / p517~517
  • General Lecture 880. Not Received / /
  • General Lecture 881. Evaluation of Cancer Chemotherapy Using Implantable Reservoirs / Y. Tsuji et al. / p517~517
  • General Lecture 882. Not Received / /
  • General Lecture 883. Therapeutic Effect on Small Hepatocellular Carcinoma / K.Sakamoto et al. / p518~518
  • General Lecture 884. Targeting Chemotherapy for Hepatoblastoma in Childhood by Arterial Administration of Anticancer Agents Dissolved in Lipiodol / N.Ohnuma et al. / p518~518
  • General Lecture 885. Chemo-embolization Therapy for the Unresectable Liver Cancer in Childhood / F.Sasaki et al. / p518~518
  • General Lecture 886. Not Received / /
  • General Lecture 887. Not Received / /
  • General Lecture 888. Clinical Evaluation of TAI and TAE Therapy for Liver Metastasis / A. Matsuba et al. / p519~519
  • General Lecture 889. Clinical Analysis of 10 Cases of Hepatocellulare Carcinoma Survived over 3 Years with Treatment of Transcatheter Arterial Embolization / S.Isomura et al. / p519~519
  • General Lecture 890. Clinical Usefulness of TAE for Postoperative Recurrent Hepatoma / E.Kyoh et al. / p519~519
  • General Lecture 891. The Role of Antineoplastic Solution in Transcatheter Hepatic Arterial Embolization -Second Report- / M.Tsuda et al. / p520~520
  • General Lecture 892. Not Received / /
  • General Lecture 893. Clinical Evaluation of SSEA-1 Antigen in Patients with Lung Cancer / S. Ikeda et al. / p520~520
  • General Lecture 894. Clinical Evaluation of Siaryl SSEA-1 Antigen for Lung Disease / K. Takaoka et al. / p520~520
  • General Lecture 895. Serum TPA(IRMA)Levels in Lung Cancer Patients / O. Nishimura et al. / p521~521
  • General Lecture 896. Study of Primary Lung Cancers Associated with High Serum CEA / M.Suyama et al. / p521~521
  • General Lecture 897. Clinical Evaluation of a New Tumor Marker, CA 130, in Patients with Lung Cancer / Y.Matsubara et al. / p521~521
  • General Lecture 898. Clinical Studies on a New Tumor-associated Antigen, ATM-1 in Lung Cancer and Mediastinal Malignant Disease / Y.Kajiyama et al. / p522~522
  • General Lecture 899. Clinical Evaluation of the Possibility of Tumor Marker Monitoring for Breast Cancer Patients Using CEA and CA 15-3 / M.Yoshimoto et al. / p522~522
  • General Lecture 900. Efficacy of Treatment for Recurrent Breast Cancer and Changes in Serum CEA / H.Imamura et al. / p522~522
  • General Lecture 901. Investigation of Tumor Markers in Cases of Progressive Recurrent Breast Cancer / K. Katayama et al. / p523~523
  • General Lecture 902. Clinical Evaluation of ATM-1 as a New Tumor Marker of Breast Cancer / M.Koike et al. / p523~523
  • General Lecture 903. Measurement of Tumor Markers in Nipple Discharge / H.Sato et al. / p523~523
  • General Lecture 904. Immunohistochemical Study of the Monoclonal Antibody DF3 in Breast Cancer / M.Nihei et al. / p524~524
  • General Lecture 905. Prognostic Usefulness of Helix Pomatia and Carcinoembryonic Antigen Histochemistry in Breast Carcinomas / T.Fukutonu et al. / p524~524
  • General Lecture 906. Hepatic Arterial Infusion Chemotherapy with Cisplatin Suspension in Lipiodol(LPS)for Hepatocellular Carcinoma / J.Shibata et al. / p524~524
  • General Lecture 907. Intraarterial Injection Therapy of CDDP-phosphatidyl Choline-lipiodol Suspension(CPLS)for Hepatoma / I.Isomoto et al. / p525~525
  • General Lecture 908. Histological Studies on CDDP-LPD Therapy for Hepatocellular Carcinoma / T.Nakanishi et al. / p525~525
  • General Lecture 909. Effect of Intra-arterially Injected Cis-platinum and Lipiodol on Rat Liver / A.Kawakami et al. / p525~525
  • General Lecture 910. Aclalubicin/Lipiodol Solution (ACR/LPD) with Meylon as a Material for Oil-Chemo-Embolization
  • Fundamental Study / Y.Terashima et al. / p526~526
  • General Lecture 911. Experimentary Evaluation of Lipiodol Chemoembolization with a New Oil Soluble Anticancer Agent KM 2210:Estradiol-chlorambucil / H.Egawa et al. / p526~526
  • General Lecture 912. Effects of TAE Following Lp Infusion into Hepatic Artery on Normal Liver in Dog / K.Kishi et al. / p526~526
  • General Lecture 913. The Experimental Study for the 5FU-MTX Sequential Chemotherapy to Metastatic Liver Tumor Using Continuous Infusion / T.Mori et al. / p527~527
  • General Lecture 914. Pharmacokinetic Analysis of ADM by Intra-arterial Chemotherapeutic Injection in Rabbit Models / H.Iwasaki et al. / p527~527
  • General Lecture 915. Not Received / /
  • General Lecture 916. Trial Manufacture and Use of CDDP Coarse Crystals as a Material for Chemoembolization -1st Report- / T.Komatsu et al. / p527~527
  • General Lecture 917. Comparison of the Effects of Intra-arterial(IA)and Intra-venous(IV)Cisplatin on Both Limb Tumor and Lung Metastases of Rats / Y.Iwamoto et al. / p528~528
  • General Lecture 918. Clinical Implications of Blood Carcinoembryonic Antigen in Stomach Cancer Patients / M.Furusawa et al. / p528~528
  • General Lecture 919. The Usefulness of CEA Determination in Gastric Cancer / H.Kuniyasu et al. / p528~528
  • General Lecture 920. Clinical Significance of Tumor Markers in Gastric Cancer / Y.Ashida et al. / p529~529
  • General Lecture 921. Clinical Evaluation of Serum Level of Carbohydrate Antigen SPan-1 in Primary Gastric Cancer / T.Kubo et al. / p529~529
  • General Lecture 922. Serum ATM1 in the Patients of Gastric Carcinoma / M. Hiraishi et al. / p529~529
  • General Lecture 923. Diagnosis of the Recurrence of Gastric Cancer after Total Gastrectomy by Urinary Pep-sinogen I / T.Yamaguchi et al. / p530~530
  • General Lecture 924. Clinical Assessment of the Tumor Marker,NCC-ST439,for Colorectal Cancer / Y.Kurosaka et al. / p530~530
  • General Lecture 925. Evaluation of a New Tumor Marker of Colon Cancer / Y. Chimori et al. / p530~530
  • General Lecture 926. Analysis of Tumor Markers on Post Operative Status in the Patient with Recurrence of Colorectal Cancer / N. Kojima et al. / p531~531
  • General Lecture 927. Not Received / /
  • General Lecture 928. Not Received / /
  • General Lecture 929. Serum and Tissue Vitamin A Levels (S-VA and T-VA) in Gastric and Colo-rectal Cancer Patients / S.Nakamura et al. / p531~531
  • General Lecture 930. Transcatheter Chemoembolization with Mitomycin C Microcapsules Combined with Lipiodol in the Treatment of Liver Cancer / T.Kato et al. / p531~531
  • General Lecture 931. Not Received / /
  • General Lecture 932. Clinical Trial of Selective Intra-arterial Chemotherapy Utilizing Microencapsulated Anticancer Drugs / K. Sato et al. / p532~532
  • General Lecture 933. Not Received / /
  • General Lecture 934. Fundamental and Clinical Studies on Prophylaxis of Hepatic Metastasis of Colorectal Cancer by Continuous Intraportal Infusion / K. Yaegashi et al. / p532~532
  • General Lecture 935. The Long Term Arterial Infusion Chemotherapy to the Patient of Metastasis and Recurrence / T.Suga et al. / p532~532
  • General Lecture 936. Two Cases of Intraperitoneal Recurrent Liposarcoma Treated by Continuous Intra-arterial Infusion Chemotherapy / T. Ohta et al. / p533~533
  • General Lecture 937. Adjuvant Therapy against Gastric Cancer with Liver Metastasis / H.Kikuchi et al. / p533~533
  • General Lecture 938. Conteneous Intraarterial Iufusion Therapy for Liver Metastasis of Large Bowel Cancer / K. Sasaki et al. / p533~533
  • General Lecture 939. Hepatic Arterial Infusion Chemotherapy of FAM in the Patients with Non-resectable Liver Metastases(The 4th Report) / Y.Arai et al. / p534~534
  • General Lecture 940. Effect of PMU Chemotherapy (Intra-arterial) for Liver Metastases of Gastric Cancer(Second Report) / N. Matsuki et al. / p534~534
  • General Lecture 941. The Low Dose-intermittent Intraarterial Infusion Chemotherapy with Implanted Silicon Reservoir to Metastatic Liver Cancer / T. Kakuta et al. / p534~534
  • General Lecture 942. Intraarterial Chemotherapy Combined with Degradable Starch Microspheres(DSM)for Liver Metastasis of Gastric Cancer and Colorectal Cancer / H.Takano et al. / p535~535
  • General Lecture 943. The Clinical Usefulness of Serum Sialyl SSEA-1 Levels in Patients with Ovarian Cancer / H. Kobayashi et al. / p535~535
  • General Lecture 944. Clinical Usefulness of Serum Sialyl SSEA-1 Antigen(SLX)in Gynecological Area / Y.Date et al. / p535~535
  • General Lecture 945. Studies on Clinical Significance of Serum Type III Procoliagen Peptide as Tumor Marker in Patients with Ovarian Tumors / T.Mori et al. / p536~536
  • General Lecture 946. Studies on the Usefulness of Tumor Marker MKS-15 (CA 54/61) in the Field of Obstetrics and Gynecology / Y.Yoshizawa et al. / p536~536
  • General Lecture 947. Detection of Serum Antibody(OVC Ab)to Cell Surface Antigen Specific for Ovarian Cancer / Y.Ogino et al. / p536~536
  • General Lecture 948. Dissociation of Tumor Markers during Chemotherapy in Ovarian Cancers / E. Kuki et al. / p537~537
  • General Lecture 949. Alteration of Tumor Markers during the Course of Chemotherapy for Ovarian Cancer / A.Tsujii et al. / p537~537
  • General Lecture 950. Studies of Serum Tumor Markers of Patients with Recurrent Ovarian Cancer / S. Morikawa et al. / p537~537
  • General Lecture 951. Clinical Significance of Discriminant Analysis (DA) Employing Three Tumor Markers [CA 125. α₁ antitrypsin (α₁ AT), TPA] for Patients (pts) with Adnexal Mass / M. Kawai et al. / p538~538
  • General Lecture 952. Application of Computer Automatic Multivariate and Pattern Analysis System (CAMPAS) to Ovarian Carcinoma in stage I--Comparing with Image Diagnosis / S. Kobayashi et al. / p538~538
  • General Lecture 953. Clinical Use of Tumor Markers in Patients with Endometrial Carcinoma / Y.Negishi et al. / p538~538
  • General Lecture 954. Placental Protein 19 in Choriocarcinoma Patient / H.Funayama et al. / p539~539
  • General Lecture 955. Pharmacokinetic Study of Adriamycin in Peripheral Blood under Intraarterial Injection / H.Iwase et al. / p539~539
  • General Lecture 956. Not Received / /
  • General Lecture 957. Phase 1 Study of Etoposide for Primary Liver Neoplasms by a Single Arterial Infusion / H.Yasuda et al. / p539~539
  • General Lecture 958. Experimental Study on Hypertensive Intraarterial Chemotherapy with Angiotensin- II--Analysis of 5-FU Concentrations Intissues of Gastric Cancer / N.Takahashi et al. / p540~540
  • General Lecture 959. Not Received / / p540~540
  • General Lecture 960. A Pharmacokinetic Study of Etoposide in Patients with Lung Cancer / R.Honda et al. / p540~540
  • General Lecture 961. Not Received / /
  • General Lecture 962. Second Line Chemotherapy for Ovarian Cancer -Report II, Parmacokinetics of BEC(BH-AC+Etoposide+CDDP)Therapy- / T.Noda et al. / p540~540
  • General Lecture 963. Pharmacokinetics of MTX and Toxities of Sequential MTX and 5-FU (MXF) Treatment / A.Nashimoto et al. / p541~541
  • General Lecture 964. Bolus and Maintenance Infusion of High-dose Methoterxate / K.Amino et al. / p541~541
  • General Lecture 965. Intravesical Chemotherapy Using an Adhensive Preparation of Peplomycin in the Treatment of Patients with Bladder Cancer / S.Tanaka et al. / p541~541
  • General Lecture 966. The Predictive Value of Serum CA-125 Levels at Second Look Operation (SLO) for Ovarian Cancer / T.Miyoshi et al. / p542~542
  • General Lecture 967. The Relation between Chronology and Tumor Marker CA 125 in Ovarian Cancer / H.Wada et al. / p542~542
  • General Lecture 968. Immunohistochemical and Ultrastructural Analysis of 4 Cases of Ovarian Immature Teratoma / S.Natsuyama et al. / p542~542
  • General Lecture 969. Ultrastructural Localization of CA 19-9 in Ovarian Cancer / M.Matsuta et al. / p543~543
  • General Lecture 970. Tumor-associated Antigen CA130 in Gynecologic Tumors:Its Immunohistochemical Distribution and Serum Levels / H.Nonogaki et al. / p543~543
  • General Lecture 971. Immunohistochemical Reactivity of CAl25,CA15-3(115D8,DF3),CA19-9,CEA,9A3,SCC,TPA,EMA and PLAP in Common Epithelial Tumors of the Ovary / K.Shigemasa et al. / p543~543
  • General Lecture 972. A Study about Release Mechanism of CA 125 from Tumor Tissue to Circulation / Y.Kiyozuka et al. / p544~544
  • General Lecture 973. Determination of Total Renin Concentration in Plasma of Children with Malignant Solid Tumors / Y.Mochida et al. / p544~544
  • General Lecture 974. New Prognostic Classification of Neuroblastoma from Disease stage,Age and N-myc Amplification / A.Nakagawara et al. / p544~544
  • General Lecture 975. Clinical Evaluation of IAP for Bone and Soft Tissue Tumor / J.Manabe et al. / p545~545
  • General Lecture 976. Thyroid Function in Cancer Bearing Rabits / Y.Hashimoto et al. / p545~545
  • General Lecture 977. Clinical Application of Cappilary Zone Electrophoresis for Polyamine Analysis / A.Hori et al. / p545~545
  • General Lecture 978. Influence of a Carcinogenic Substance, ENNG, and an Immunoactivator,RBS(Rice Bran Saccharide),on the Rat Polyamine Fraction Value / I Takeyoshi et al. / p546~546
  • General Lecture 979. A Study of the Pharmacodynamics Following Oral Dosages of Pyrimidine Fluorides in Breast Cancer / A.Kosaka et al. / p546~546
  • General Lecture 980. A Study of Pre-operative Chemotherapy in Colorectal Carcinoma / H.Sawa et al. / p546~546
  • General Lecture 981. 5-FU Concentration in Tissue of Colorectal Cancer after Intrarectal Administration of FT-207 / K.Ishimoto et al. / p547~547
  • General Lecture 982. 5-FU Concentration in Serum and Tissue of the Patients with Renal Cell Carcinoma after Oral Administration of UFT / S.Ozono et a1. / p547~547
  • General Lecture 983. Study on the Concentration of Uracil in Normal and Tumor Tissue with or without UFT Administration(2nd Report) / T.Komita et al. / p547~547
  • General Lecture 984. Not Received / /
  • General Lecture 985. The Long-term Effect on Serum 5-FU Concentration of Administration of UFT / Y.Yamamoto et al. / p548~548
  • General Lecture 986. Fraction of HCFU and Concentration of 5-FU in the Blood of Postoperative Patient with Digestive Tract Cancer after Oral Administration of HCFU / Y.Kuroda et al. / p548~548
  • General Lecture 987. Clinical Evaluation of Anti-tumor Effects and Side Effect on the Combined Use of 5FU and L-cysteine in the Treatment of Gastric Cancer / I.Mizuno et al. / p548~548
  • General Lecture 988. 5-Fu and Uracil Concentration and Thymidylate Synthase Inhibition Rates in Cancer with Continuous Infusion of Tegafur / A.Yagawa et al. / p549~549
  • General Lecture 989. Not Received / /
  • General Lecture 990. Bioassay of Cisplatin and Doxorubicin by HeLa Cell Clonogenic Assay / Y.Hayashi et al. / p549~549
  • General Lecture 991. Determination of Unchanged Cisplatin(CDDP)in Plasma and Urine of the Patients by HPLC Using Post-column Reaction Detector / M.Kinoshita et al. / p549~549
  • General Lecture 992. Phase II Study of Carboplatin in Untreated Non-small Cell Lung Cancer / S.Ryu et al. / p550~550
  • General Lecture 993. Pilot Study of Combination Chemotherapy with CDDP and CBDCA for Non-small Cell Lung Cancer / M.Shibuya et al. / p550~550
  • General Lecture 994. Not Received / /
  • General Lecture 995. Combination Chemotherapy with Adriamycin, Carboplatin, and Etoposide for the Patients with Small Cell Lung Cancer(SCLC)--Preliminary Study / S.Negoro et al. / p550~550
  • General Lecture 996. Adriamycin,Cisplatin,and Etoposide Combination Chemotherapy for Small Cell Lung Cancer / J Fujita et al. / p551~551
  • General Lecture 997. Combination High-dose(HD)Etoposkle(E)/Cisplatin(D)Chemotherapy for Recurrent Small Cell Lung Cancer(SCLC) / N.Masuda et al. / p551~551
  • General Lecture 998. Randomized Trial of Combination Chemotherapy with Mitomycin(M),Vindesine(V)and Cisplatin(P)in Non-small Cell Lung Cancer(NSCLC) / T.Shinkai et al. / p551~551
  • General Lecture 999. Comparison of Vindesine plus Cisplatin or Mitomycin plus Cisplatin in the Treatment of Non-small Cell Lung Cancer / E.Shimizu et al. / p552~552
  • General Lecture 1000. Phase II Study of Ifosfamide in Patients with Non-small Cell Lung Cancer / N.Kashima et al. / p552~552
  • General Lecture 1001. Informed Consent about Anticancer Chemotherapy to the Family of Patients with Cancer / H.Tazawa et al. / p552~552
  • General Lecture 1002. Phase I/II Study of 5-florouracil(5-FU)plus High-dose Leucovorin(LCV)in Advanced Non-small Cell Lung Cancer(NSCLC)and Metastatic Cancer to the Lung / Y.Ohe et al. / p553~553
  • General Lecture 1003. Clinical Results of UFT plus Anticoagulants as Post-operative Adjuvant in Lung Cancer Patients / J.Ogawa et al. / p553~553
  • General Lecture 1004. Phase II(P II)Trial for Previously Untreated Small Cell Lung Cancer(SCLC) / K.Matsui et al. / p553~553
  • General Lecture 1005. Clinical Study of Combination Chemotherapy with Cisplatin(CDDP)and Vindisine(VDS)for Advanced Non-small Cell Lung Cancer / T.Goto et al. / p554~554
  • General Lecture 1006. Phase II Study of a Three-Drug Combination of Ifosfamide, Cisplatin and Vindesine in Non-Small Cell Lung Cancer / A.Kozuka et al. / p554~554
  • General Lecture 1007. Clinical Evaluation of CAV-EP Alternative Chemotherapy for Small Cell Lung Cancer / J.Mukai et a1. / p554~554
  • General Lecture 1008. Evaluation of Alternating Chemotherapy for Small Cell Lung Cancer(SCLC)--Randomized Controlled Study / M.Kawahara et al. / p555~555
  • General Lecture 1009. CAV-PVP Hybrid Chemotherapy for Small Cell Lung Cancer(SCLC) / T.Moritaka et al. / p555~555
  • General Lecture 1010. Not Received / /
  • General Lecture 1011. Clinical Trial of Carboplatin in Malignant Lymphoma / M.Nishikawa et al. / p555~555
  • General Lecture 1012. The Comparative Study of Adriamycin(ADM)and 4-O-Tetrahydropyranyl Doxorubicine(THP)in the Treatment of Non-Hodgkin Lymphoma, Intermediate Grade and Immunoblastic Type(CHOP vs COP-THP) / A.Oyama et al. / p556~556
  • General Lecture 1013. Clinical Evaluation of Combination Chemotherapy Including Etoposide for Refractory Acute Leukemia and Malignant Lymphoma / M.Komatsuda et al. / p556~556
  • General Lecture 1014. Pharmacokinetic and Clinical Study of Intermediate Dose Ara-C Therapy(IDAra-C)in Patients with Acute Leukemia / T.Ueda et al. / p556~556
  • General Lecture 1015. Phorbol Esters Potentiate Glucocorticoid-induced Cytotoxicity in CEM-C7 Human T-Leukemia Cell Line / K.Sato et al. / p557~557
  • General Lecture 1016. Vincristine and Prednisolone(VP)and VMP(VP+6MP)Treatment for Patients with CML Crisis / Y.Araki et al. / p557~557
  • General Lecture 1017. Treatment for stage II Non-Hodgkin's Lymphomas of the Waldeyer's Ring / T.Takenaka et al. / p557~557
  • General Lecture 1018. Combined Modality for Localized Primary Head and Neck Non-Hodgkin's Lymphomas / Y.Kuraishi et al. / p558~558
  • General Lecture 1019. A Result of a Salvage Chemotherapy for Non-Hodgkin's Lymphomas(NHL)
  • 4 Drug Combination of Mitoxantrone,Etoposide,Cisplatin and Prednisolone(MEPP) / K.Ueno et al. / p558~558
  • General Lecture 1020. Result of MCVP Chemotherapy for Recurrent or Refractory Non-Hodgikin's Lymphoma / K.Okabe et al. / p558~558
  • General Lecture 1021. An Alternating Combination Chemotherapy for Diffuse Aggressive Lymphomas with CHOPB and POEMB / J.Mizuta et al. / p559~559
  • General Lecture 1022. A Study on Lung Cancer after Curative Resection / Y.Uchiyama et al. / p559~559
  • General Lecture 1023. Surgical Treatment of Renal Cell Carcinoma with Lung Metastases / A.Sasaki et al. / p559~559
  • General Lecture 1024. Cytoreductive Surgery for Pulmonary Metastases of Gonadal Germ Cell Tumor / T.Goya et al. / p560~560
  • General Lecture 1025. Surgical Treatment of Pulmonary Metastases / H.Suda et al. / p560~560
  • General Lecture 1026. Surgical Treatment of Metastatic Spinal Tumors / T.Kushimoto et al. / p560~560
  • General Lecture 1027. Score Assessment on Metastatic Tumor of the Spine for Operative Treatment / Y.Tokuhashi et al. / p561~561
  • General Lecture 1028. Serial Changes of Serum CA 125 Levels Following Treatment for Ovarian Cancer
  • Relation with Findings at Second Look Operation(SLO)and Their Clinical Courses / K.Kuzuya et al. / p561~561
  • General Lecture 1029. Clinical Assessment of Patient with Second-Look Operation / M.Miyauchi et al. / p561~561
  • General Lecture 1030. Second-look Laparoscopy on Patients with Ovarian Cancer / T.Shinozuka et al. / p562~562
  • General Lecture 1031. Our Experience of the Second Look-operation in the Management of Ovarian Cancer / K.Tanaka / p562~562
  • General Lecture 1032. Clinico-pathological Studies on stage Ia Cervical Carcinoma of Uterus by New FIGO Classification--Choice of Radical or Semiradical Hysterectomy for Ia₂ Carcinoma / K.Katoh et al. / p562~562
  • General Lecture 1033. The Significance on Diagnostic Para-aortic and Pelvic Lymph Nodes Sampling in Early Ovarian Carcinoma / H.Tsunoda et al. / p563~563
  • General Lecture 1034. A Few Problems in the Primary Surgery of Ovarian Cancer / S.Takeuchi et al. / p563~563
  • General Lecture 1035. A Study of Pelvic Exenteration Performed for Gynecologic Advanced Malignancies / T.Ohisi et al. / p563~563
  • General Lecture 1036. Cases Undergoing Total Pelvic Exenteration and Indications for This Operation / M.Tamura et al. / p564~564
  • General Lecture 1037. Operative Procedure for Gastric Cancer in the Greater Curvature from the Viewpoint of Lymphatic Flow / K.Sawai et al. / p564~564
  • General Lecture 1038. Analysis of Mediastinal Lymph Node Metastasis from Gastric Cancer Invading the Esophagus / M.Sasako et al. / p564~564
  • General Lecture 1039. Not Received / /
  • General Lecture 1040. Not Received / /
  • General Lecture 1041. Study on Cases of Borrmann 4 Type Gastric Cancer Resection / H.Motohashi et al. / p565~565
  • General Lecture 1042. Results of Surgical Treatment for Borrmann Type 4 Gastric Cancer / Y.Yonemura et al. / p565~565
  • General Lecture 1043. Clinical Evaluation of Postoperative Condition Long after Left Upper Abdominal Evisceration plus Appleby's Method for Gastric Cancer / H.Furukawa et al. / p565~565
  • General Lecture 1044. Relative Non-curative Resection of Gastric Cancer--Its Results and Problems / M.Hiratsuka et al. / p566~566
  • General Lecture 1045. Prognostic Factors of Gastric Cancer with Serosal Invasion / H.Habu et al. / p566~566
  • General Lecture 1046. Evaluation of Surgical Treatment for stage IV Gastric Cancer / H.Kanesada et al. / p566~566
  • General Lecture 1047. Vascular Reconstruction in Hepatectomy in the Treatment of Hepatic Tumors / K.Mori et al. / p567~567
  • General Lecture 1048. Five-year Survivals after Surgical Resection of Primary Hepatocellular Carcinomas / T.Shibata et al. / p567~567
  • General Lecture 1049. Not Received / /
  • General Lecture 1050. Block Resection of Hepatoduodenal Ligament for Carcinoma of the Bile Duct and Gallbladder--Evaluation of the Operative Procedure from a Viewpoint of Pathology / T.Mori et al. / p567~567
  • General Lecture 1051. Evaluation of Resection of the Pancreas for Ampullary Carcinoma / T.Manabe et al. / p568~568
  • General Lecture 1052. Prognostic Factors and It's Quantification in Advanced Ovarian Carcinoma / K.Kamioka et al. / p568~568
  • General Lecture 1053. Treatment of Ovarian Cancer(stage III) / K.Yamamoto et al. / p568~568
  • General Lecture 1054. The Role of Percutaneous Nephrostomy in Advanced Uterine Cervical Cancer / K.Sakumoto et al. / p569~569
  • General Lecture 1055. A Plan of Management for Localized Renal Cell Carcinoma / F.Masuda et al. / p569~569
  • General Lecture 1056. A Study of Testicular Tumors Treated at Our Clinic According to the Protocol of East Japan Testicular Tumor Study Group(EJTTSG) / Y.Hosaka et al. / p569~569
  • General Lecture 1057. Evaluation of Treatment in Patients with Refractory Germ Cell Cancer / S.Hida et al. / p570~570
  • General Lecture 1058. Pre-radiotherapy Chemotherapy for Advanced Esophageal Carcinoma / H.Sueyama et al. / p570~570
  • General Lecture 1059. Multidisciplinary Treatment of Esophageal Carcinoma Based on Preoperative Staging / H.Ide et al. / p570~570
  • General Lecture 1060. An Adjuvant Chemo-therapy against Esophageal Cancer after Radiation Therapy / Y.Hishikawa et al. / p571~571
  • General Lecture 1061. Effects of Surgical Adjuvant Chemotherapy for Gastric Cancers with Serosal Invasion / J.Fujimoto et al. / p571~571
  • General Lecture 1062. Not Received / /
  • General Lecture 1063. Therapeutic Result of the Paranasal Sinus Cancer in Our Hospital / Y.Sakamoto et al. / p571~571
  • General Lecture 1064. A Retrospective Study of 250 Cases of Carcinoma of the Maxillary Sinuses According to Periods and Methods of Treatment / K.Tanaka et al. / p572~572
  • General Lecture 1065. Radiotherapy Combined with Concomitant Doxorubicin for Hypopharynx Carcinoma / K.Nishiyama et al. / p572~572
  • General Lecture 1066. Clinico-histopathologic Studies of Oral Squamous Cell Carcinomas Treated with Neoadjuvant Therapy / T.Yamamoto et al. / p572~572
  • General Lecture 1067. Not Received / /
  • General Lecture 1068. Combination Therapy of OK-432 Intra-vesselally and Conventional Anti-cancer Drugs to Liver Cancer / A.Gohchi et al. / p573~573
  • General Lecture 1069. An Attempt to Evaluate the Antitumor Effect of the Therapy by the Aspiration Cytology / Y.Iitsuka et al. / p573~573
  • General Lecture 1070. Multimodality Treatment on Biliary Tract Cancer / M.Yonekawa et al. / p573~573
  • General Lecture 1071. Clinical Study on Adjuvant Therapy to Operation of Carcinomas of the Pancreas and Biliary Tract--Tolerance to Adjuvant Chemotherapy / H.Hasegawa et al. / p574~574
  • General Lecture 1072. Combination Therapy of Natural Human TNF-α + Natural Human IFN-α(OH-1)and Anticancer Agent / F.Hamada et al. / p574~574
  • General Lecture 1073. Flow Cytometry Analysis of Cytokinetics of Pancreatic Adenocarcinoma Cell Line after Hyperthermia,Chemotherapy, or Radiation / B.Nakata et al. / p574~574
  • General Lecture 1074. Whole Abdominal Irradiation by the Moving-strip Technique for Malignant Abdominal Tumor with Peritoneal Dissemination / S.Sugahara et al. / p575~575
  • General Lecture 1075. Results of Combination Therapy with Tumor Resection, Intraperitoneal Infusion Chemotherapy(IPIC)and Whole Abdominal Irradiation for Patients with Severe Peritoneal Seedings of Gastrointestinal Malignancies / T.Todoroki et al. / p575~575
  • General Lecture 1076. Extended Radical Mastectomy Using Preoperative Injection of Activated Carbon Particle(CH40) / T.Asaga et al. / p575~575
  • General Lecture 1077. Multidisciplinary Treatment for Inflammatory Breast Cancer / M.Yoshida et al. / p576~576
  • General Lecture 1078. Efficacy of Radiation Combined with Chemo-endocrine Therapy in Advanced/Recurrent Breast Cancer / T.Okawa et al. / p576~576
  • General Lecture 1079. Not Received / /
  • General Lecture 1080. Treatment of Non Hodgkin's Lymphoma in Eary stage / T. Yoshida et al. / p576~576
  • General Lecture 1081. Results of Radiation Therapy for Stage I-II Non-Hodgkin's Lymphoma Localized in the Head and Neck--A Report of the Japanese Lymphoma Radiation Therapy Study Group / N.Masaki et al. / p577~577
  • General Lecture 1082. A Preliminary Treatment Report of the Study Group of Japan for Advanced Neuroblastoma / S.Sawaguchi et al. / p577~577

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology

Nihon gan chiryo gakkaishi
巻冊次 24(2)
出版元 日本癌治療学会
刊行年月 1989-02
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想